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42 NTP/NIEHS
Synonyms: alpha-nitronaphthalene, nitronaphthalene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-65 Bioassay ofChloropicrin for
Possible Carcinogenicity (CAS No. 76-06-2)
Chloropicrin is an agricultural fumigant, once widely
usedbutnowbeingphased out. Itwasdevelopedasatear
gas, butwasfoundtobeuseful as afumigantin1918.The
primary use of chloropicrin as a fumigant was in the
treatment of stored grain. It also functions as a
nematicide, fungicide, and insecticidewhenused as a soil
fumigant prior to planting.
Abioassayoftechnical-grade chloropicrinforpossible
carcinogenicity was conducted using Osborne-Mendel
rats and B6C3F1 mice. Chloropicrin in corn oil was
administered 5 days a week by gavage, at either of two
dosages, to groups of 50 male and 50 female animals of
each species. Time-weighted average dosages of25 mg/
kg/day for low dose male rats and 20 mg/kg/day for low
dose female rats were administered during weeks 1
through 33, then administered cyclically (1 dose-free
week followed by 4weeks ofadministration) fromweeks
34through78.Time-weighted averagedosages of26mg/
kg/dayforhighdosemaleratsand22mg/kg/dayforhigh
dose female rats were administered from weeks 1
through 17, weeks 31 through 33, and cyclically (1 dose-
freeweek followed by4weeks ofadministration) during
weeks 34through 78. Time-weighted average dosages of
66 and 33 mg/kg/day, respectively, for male and female
mice were administered for 78 weeks. These dosing
regimens were followed by observation periods of 32
weeks for rats and 13 weeks for mice.
Foreachspecies,20animalsofeach sexwereplaced on
test as vehicle controls. These animals were gavaged
with corn oil. Twenty animals ofeach sexwereplaced on
test as untreated controls for each species. These ani-
malswere notgavaged.
A high incidence of early death was observed among
chloropicrin-dosed rats. Deaths among dosed rats
occurred as early as week 1 for females and week 6 for
males. Median survivalwasweek48forhigh dosemales,
week54forlowdosemales,week70forhighdosefemales
and week 59 for low dose females. Statistical tests indi-
cate a positive association between chloropicrin dosage
and mortality ofrats.
No neoplasms were observed at higher incidences in
dosed than control rats. In rats ofboth sexes, incidences
of adenoma of the pituitary and of adenocarcinoma or
fibroadenoma of the mammary gland were higher in
control groups than dosed groups. It is likely that most
dosed rats did not survive longenough tobe atriskfrom
late-appearing tumors.
Arapid decrease in survival after the firstyear ofthe
studywas observed amonghigh dose mice ofboth sexes.
Survival of high dose male mice decreased from 80
percent in week 54 to 26 percent in week 90. Survival of
highdosefemalemicedecreasedfrom82percentinweek
54 to 36 percent in week 90.-Statistical tests indicated a
positive association between chloropicrin dosage and
mortality ofmice.
In chloropicrin-dosed mice, proliferative lesions ofthe
squamous epithelium of the forestomach included two
carcinomas andapapilloma.Althoughthesetumorswere
uncommon in control animals, statistical analysis did not
demonstrate that they were related to administration of
chloropicrin. Other proliferative lesions of the for-
estomach occurring at an increased incidence in dosed
mice were acanthosis and hyperkeratosis. No statis-
tically significant increase of tumor incidence was
observed in mice.
The bioassay of chloropicrin using Osborne-Mendel
rats did not permit an evaluation of carcinogenicity
because ofthe short survival time ofdosed animals. The
bioassay of chloropicrin using B6C3F1 mice did not
provide conclusive statistical evidence for the car-
cinogenicity ofthis compound.
Synonyms: trichloronitromethane, nitrochloroform
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Inadequate Study
Female Rats: Inadequate Study
Male Mice: Negative
Female Mice: Negative
TR-66 Bioassay of1,1-Dichloroethane for
Possible Carcinogenicity (CAS No. 75-34-3)
1,1-Dichloroethane is used as a chemical intermediate
and as a solvent for extraction and degreasing.
A bioassay of technical-grade 1,1-dichloroethane for
possible carcinogenicity was conducted using Osborne-
Mendel rats and B6C3F1 mice. 1,1-Dichloroethane in
corn oil was administered by gavage, at either of two
dosages, to groups of50 male and 50 female animals of
each species, 5 days a week for a period of 78 weeks,
followed by an observation period of 33 weeks for rats
and 13 weeks for mice.
Apreliminary subchronic toxicity test, consisting of6
weeksof1,1-dichloroethane administration atfivedosage
levelsfollowedby2weeks ofobservation, wasperformed
for the purpose of selecting initial dosages. Subsequent
dosage adjustments were made during the course ofthe
study. The high and lowtime-weighted average dosages
of1,1-dichloroethane were, respectively, 764 and 382 mg/
kg/day for male rats; 950 and 475 mg/kg/day for female
rats; 2,885 and 1,442 mg/kg/day for male mice; and 3,331
and 1,665 mg/kg/day for female mice.ABSTRACTS FROMLONG-TERM CANCER STUDIES, 1976-1992
Foreachspecies,20animalsofeach sexwereplaced on
test as vehicle controls. These animals were gavaged
with corn oil at the same times that dosed animals were
gavaged with 1,1-dichloroethane mixtures. Twenty ani-
malsofeachsexwereplacedontestasuntreatedcontrols
for each species. These animals were not intubated.
Survival was poor in all rat groups and several mouse
groups. Survival at the end ofthe studyin theuntreated
control, vehicle control, low dose, and high dose groups
was, respectively, 30, 5, 4, and 8 percent in male rats; 40,
20, 16 and 18 percent in female rats; 35, 55, 62 and 32
percent in male mice; and 80, 80, 80 and 50 percent in
female mice. Pneumonia was observed in 80 percent of
the rats in this bioassay.
There were dose-related marginal increases in mam-
mary adenocarcinomas and in hemangiosarcomas
among female rats and there was a statistically signifi-
cant increase in the incidence of endometrial stromal
polyps amongdosedfemalemiceascomparedtocontrols.
Thesefindings areindicative ofthepossible carcinogenic
potential of the test compound. However, it must be
recognized that under the conditions of this bioassay
there was no conclusive evidence for the carcinogenicity
of1,1-dichloroethane in Osborne-Mendel rats orB6C3Fj
mice.
Synonym: ethylidene dichloride
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Equivocal
Negative
Equivocal
TR-67 Bioassay of a Mixture ofAspirin,
Phenacetin, and Caffeine for Possible
Carcinogenicity (CAS No. 8003-03-0)
APC, an abbreviation often used for mixtures of
aspirin, phenacetin and caffeine, is a nonprescription
analgesic preparation sold for reliefofheadache, muscu-
lar aches and pains, arthritis, and other common afflic-
tions. APC is also antipyretic and anti-inflammatory and
also acts as a central stimulant.
A bioassay of a mixture of aspirin, phenacetin, and
caffeine (APC) forpossible carcinogenicity was conducted
usingFischer344 rats and B6C3F1 mice.APC was admin-
istered in the feed, at either of two concentrations, to
groups of 50 male and 49 or 50 female animals of each
species. For each species, 50 animals of each sex were
placed ontest ascontrols. Thehighdoseusedinthechronic
study for the male and female rats and mice was 1.4
percent. Thelowdose administered tothemale and female
rats and mice was 0.7 percent. After a 78-week period of
compound administration, observation of the rats con-
tinued for up to an additional 35 weeks and observation of
the mice continued for an additional 16 weeks.
No significant association was established between
administration of APC and mortality in rats or female
mice; however, there was a significant positive associa-
tion between treatment and mortality in male mice. For
both species the survival in all groups was adequate for
statistical analysis oftumor incidence.
In rats, a variety of endocrine tumors were observed
withgreaterfrequencyinthemaleratstreatedwithAPC
than in the male control rats. These same tumors were
not observed with similar frequencies in the female rats
or in the mice of either sex. The endocrine tumors
observed most frequently in the treated male rats were
adenomas and carcinomas of the pituitary gland. The
incidences of these tumors proved to be statistically
inconclusive.
In rats, a transitional-cell carcinoma of the bladder
was observed in one lowdose and one high dose females.
Atubular-cell adenocarcinoma ofthe kidneywas seen in
one low dose female and one low dose male. A fifth
neoplasm, atransitional-cellpapillomaofthe kidney,was
seen in one high dose female. The occurrence of these
urinary tumors, although considered important, was not
statistically significant.
In mice, there was no statistically significant positive
association between APC administration and the inci-
dence oftumors in either sex.
Underthe conditions ofthisbioassayevidencewas not
sufficient for the carcinogenicity ofAPC in Fischer 344
rats or in B6C3F1 mice.
Synonyms for APC: 2-(acetyloxy)-benzoic acid, mixture
with N-(4-ethoxy-phenzl) acetamide and 3,7-dihydro-
1,3,7-trimethyl-lH-purine-2,6-dione
Synonym for aspirin: acetylsalicylic acid
Synonym for phenacetin: p-acetophenetidide
Synonym for caffeine: theine, 1,3,7-trimethylxanthine
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Equivocal
Male Mice: Negative
Female Mice: Negative
TR-68 Bioassay of Hexachloroethane for
Possible Carcinogenicity (CAS No. 67-72-1)
Hexachloroethaneisused as aveterinaryanthelmintic
for control of liver and stomach flukes in domestic ani-
mals. Itis also used as a solvent, acamphor substitute in
thepreparation ofCelluloid®, arubbervulcanizing accel-
erator, a retarding agent in fermentation, and in explo-
sives, pyrotechnics, and smoke devices.
A bioassay for possible carcinogenicity of technical-
grade hexachloroethane was conducted using Osborne-
MendelratsandB6C3F1 mice. Hexachloroethane in corn
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oilwas administered bygavage, ateitheroftwo dosages,
to groups of 50 male and 50 female animals of each
species. The chemical was administered 5 days a week,
cyclically for 44 of78 weeks in rats and continuously for
78weeks inmice, followedbyanobservationperiod of33
or34weeksforrats and12or13weeksformice. Thehigh
and low time-weighted average dosages of hex-
achloroethane were, respectively, 423 and 212mg/kg/day
formale and female rats and 1179 and 590mg/kg/dayfor
male and female mice. For each species, 20 animals of
each sex were placed on test as vehicle controls. These
animalsweregavagedwithpurecorn oil atthe samerate
as the high dose group ofthe same sex. Twenty animals
ofeach sexwere placed on test as untreated controls for
each species. These animals were not intubated.
A statistically significant association between increased
dosageandacceleratedmortalitywasobservedinmaleand
female rats but not in mice ofeither sex.
Toxic tubular nephropathywas observed in all groups
oftreated animals.
Statistical evaluation ofthe incidences ofhupatocellu-
larcarcinomas revealed asignificantpositive association
between hexachloroethane administration and tumor
incidence in both male and female mice. No statistical
significance was attributed to the incidence of any neo-
plasm in rats ofeither sex.
No evidence was provided for the carcinogenicity of
the compound in Osborne-Mendel rats. It is concluded
that under the conditions of this bioassay, hex-
achloroethane was carcinogenic in B6C3F1 mice, induc-
inghepatocellular carcinomas in both sexes.
Synonyms: carbon hexachloride, perchloroethane, eth-
ylenehexachloride
Trade Name: Avlothane®
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
Note: Hexachloroethane was subsequently studied by
gavage administration to F344 rats (See TR-361,
reported 1989).
TR-69 Bioassay ofAzinphosmethyl for
Possible Carcinogenicity (CAS No. 86-50-0)
Azinphosmethyl is abroad-spectrum, organophospho-
rusinsecticidethatwasfirstproducedin1953andisused
solely for agricultural purposes. In 1974, 3.1 million
pounds were estimated to be have been used in the
United States on the following crops: alfalfa, cotton,
deciduous fruits and nuts, tobacco, vegetables and some
miscellaneous items.
A bioassay of technical-grade azinphosmethyl for
possiblecarcinogenicitywasconductedbyadministering
the test chemical in feed to Osborne-Mendel rats and
B6C3F1 mice.
Groups of 50 rats of each sex were administered
azinphosmethyl at one of two doses for 80 weeks, then
observed for 34 or 35 weeks. Time-weighted average
doses of either 78 or 156 ppm were used for the males.
Initialdosesof62.5or125ppmusedforthefemaleswere
maintained throughout the bioassay. Matched controls
consisted of groups of 10 untreated rats of each sex;
pooled controls consisted of the matched controls com-
bined with 95 male and 95 female untreated rats from
similarbioassaysof10othertestchemicals.Allsurviving
rats were killed at 114 or 115 weeks.
Groups of 50 mice of each sex were administered
azinphosmethyl at one of two doses for 80 weeks, then
observedfor12or13weeks.Thedoseswereeither31.3 or
62.5ppmforthemales and either62.5 or125 ppmforthe
females. Matched controls consisted of groups of 10
untreated mice ofeach sex; pooled controls consisted of
the matched controls combined with 130 male and 120
female untreated mice from similarbioassays of11 other
test chemicals. All surviving mice were killed at 92 or 93
weeks.
High- and low-dose male rats and mice and high-dose
female rats and mice had lower mean bodyweights than
corresponding matched controls throughout the bio-
assay. Typical signs of organophosphate intoxication
were observed in a few animals of both species, and
included hyperactivity, tremors, and dyspnea. Sufficient
numbers of animals were at risk in each species for
development oflate-appearing tumors.
A great many tumors of the endocrine organs were
observed in both dosed male and dosed female rats.
Those of the adrenal in dosed males and females, the
follicular cells ofthe thyroid in dosed females, the ante-
rior pituitary in dosed males, and the parathyroid in
dosed males occurred at statistically significant inci-
denceswhencomparedwithpooledcontrols,butnotwith
matched controls, and they were not considered to be
related to administration of the test compound. The
incidences of tumors of the pancreatic islets and of the
follicularcells ofthethyroidinthemalerats suggest,but
do not clearly implicate, azinphosmethyl as a carcinogen
in these animals.
Inmice ofeach sextherewere noincreasedincidences
of tumors that could be related to administration ofthe
test chemical.
It is concluded that under the conditions of this bio-
assay, neoplasms of the thyroid and pancreatic islets
suggest but do not provide sufficient evidence for the
carcinogenicity of azinphosmethyl in male Osborne-
Mendel rats. Azinphosmethyl was not shown to be car-
cinogenic in female Osborne-Mendel rats or in B6C3Fj
mice ofeither sex.
Synonym: 0,0-dimethyl-S-[(4-oxo-1,2,3-benzotri-
azin-3-(4H)-yl)methyl]phosphorodithioate
Trade Name: Guthiong
Report Date: 1978
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Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Equivocal
Negative
Negative
Negative
TR-70 Bioassay ofParathion for Possible
Carcinogenicity (CAS No. 56-38-2)
Parathion is an organophosphorus pesticide thatis rela-
tively nonpersistent in the environment, with high activity
against insects and mites. It is used as an insecticide and
acaricide on a wide variety offruit and nut trees, berries,
vegetables, field crops, and ornamental plants.
A bioassay for possible carcinogenicity of technical-
gradeparathionwasconductedbyadministeringthetest
chemical inthe dietto Osborne-Mendel rats andB6C3Fj
mice.
Groups of 50 rats of each sex were administered
parathion atoneoftwodosesfor80weeks,thenobserved
for 32 or 33 weeks. Time-weighted average doses for
males were 32 or 63 ppm; forfemales, theywere 23 or45
ppm. All surviving rats were killed at 112 or 113 weeks.
Groups of 50 mice of each sex were administered para-
thion at one oftwo doses, either 80 or 160 ppm. The low-
dose males were administered parathion for 71 weeks;
thehigh-dose males for62weeks; and thelow- and high-
dose females for 80weeks. The animals were then main-
tained for observation and all survivingmicewere killed
at 89 or 90 weeks. Matched controls consisted ofgroups
of10untreated rats ormiceofeachsex;pooledcontrolsof
rats or mice taken from similar bioassays of other test
chemicals were also used.
Mean bodyweights ofhigh-dose male and female rats
andofhigh-andlow-dosemalemiceweregenerallylower
than those ofthe matched controls during the period of
administrationofthechemical. Meanbodyweightsofthe
other groups of dosed rats and mice did not differ
appreciably from those of the matched controls. Since
body weights and survival of the female mice were not
affected, female mice may have been able to tolerate a
higher dose. Sufficient numbers of male and female
animals ofboth species were at risk for the development
oflate-appearing tumors.
Inbothmale andfemalerats, theincidences ofcortical
adenomas or carcinomas of the adrenal showed dose-
related trends (P<0.001) using pooled controls and, in
direct comparisons, were higher in the high-dose groups
(P<0.001) than in the pooled controls (males: pooled
controls 3/80, matched controls 0/9, low-dose 7/49, high-
dose 11146; females: pooled controls 4/78, matched con-
trols 1110, low-dose 6/47, high-dose 13/42). Most of the
tumorswereadenomas. Whenthematchedcontrolswere
used, dose-related trends in incidences of the adrenal
tumors were significant (males, P = 0.048; females,
P =0.028);in direct comparisons, however, theincidences
of the tumors in the individual groups did not differ
signiflcantly from those in corresponding matched con-
trols. Theincidences ofthetumors inthe dosedmale and
female rats were higher than those in corresponding
historical controls (males 8/148, females 5/180).
Inmice, notumors occurredineither sexatincidences
thatweresignificantlyhigherinthedosedgroupsthanin
the corresponding control groups.
It is concluded that under the conditions of this bio-
assay, parathion was not carcinogenic to B6C3F1 mice.
In the male and female Osborne-Mendel rats receiving
parathion in their diet, there was a higher incidence of
corticaltumorsoftheadrenalthaninpooledorhistorical
controls, suggesting that parathion is carcinogenic to
this strain ofrat.
Synonym: 0,0-diethyl-0-4-nitrophenylphosphorothioate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Equivocal
Equivocal
Negative
Negative
TR-71 Bioassay ofL-fryptophan for
Possible Carcinogenicity (CAS No. 73-22-3)
L-Tryptophanisanessentialaminoacidforhumans,and
a precursor of the neurohormones serotonin (5-
hydroxytryptamine) and melatonin (N-acetyl-5-
methoxytryptamine), and the Bvitamin nicotinic acid. Itis
foundin small concentrations incasein, andinmanyfoods.
AbioassayoftheaminoacidL-tryptophanforpossible
carcinogenicitywas conductedbyadministeringthe test
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of 35 rats and 35 mice of each sex were
administered L-tryptophan at one of two doses, either
25,000 or 50,000 ppm, 5 days perweek for 78weeks, and
then observed for 26 or 27 weeks. Matched controls
consisted ofgroups of15 rats or 15 mice ofeach sex. All
surviving rats and mice were killed at 104 or 105 weeks.
L-Tryptophan had little toxic effect on the rats; mean
bodyweightlosswasminimalandsurvivalofdosedgroups
ofboth sexes was high. In the mice, mean bodyweights of
dosed animals were lower than those ofcontrols through-
outmostofthebioassay,particularlyinthefemales. Suffici-
entnumbersofratswereatrisktoterminationofthestudy
for development of late-appearing tumors, and sufficient
numbers ofmicewere atriskbeyond 52weeksofthestudy
for development oftumors.
No neoplasms occurred in a statistically significantinci-
dence among dosed ratswhen comparedwith controls.
In both male and female mice, neoplasms ofthe hema-
topoietic system occurred at higher incidences in the low-
dose groups than in the matched-control groups (males:
controls 0/12, low-dose 9/34, high-dose 2/33; females: con-
trols 2/13, low-dose 6/33, high-dose 1135). These incidences,
however, are not statistically significant, usingthe Bonfer-
ronicorrection, andtherefore, no tumors are considered to
be related to the administration ofthe test chemical.
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It is concluded that under the conditions of this bio-
assay, L-tryptophan was not carcinogenic for Fischer
344 rats or B6C3F1 mice.
Synonym: L-ao-amino-13-indolepropionic acid
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-72 Bioassay ofPhenoxybenzamine
Hydrochloride for Possible Carcinogenicity
(CASNo.63-92-3)
Phenoxybenzamine hydrochloride is an antihyperten-
sive agent that is used in controlling specific hyperten-
sive crises such as those that result from high blood
levels ofsympathomimetic amines.
A bioassay of phenoxybenzamine hydrochloride for
possible carcinogenicity wasconductedbyadministering
thetestchemicalbyintraperitoneal injectiontoSprague-
Dawley rats and B6C3F1 mice.
Groups of 35 rats of each sex were administered
phenoxybenzamine hydrochloride at one of two doses,
either 5 or 10 mg/kg body weight, three times per week
for 52 weeks, then observed for an additional 31 or 32
weeks. The vehicle used for most of the period of the
bioassay was 6% propylene glycol in saline, although
other vehicles, including 0.05% polysorbate 80 in saline,
wereused atthebeginning. Controls consisted ofgroups
of 10 vehicle controls and 10 untreated controls of each
sex. All surviving rats were killed at 83-85 weeks.
Groups of 35 mice of each sex were administered
phenoxybenzamine hydrochloride at one of two doses,
either 12.5 or 25 mg/kg body weight, three times per
week for 50 or 52 weeks, then observed for an additional
31-33weeks. Controls consisted ofgroups of15malesand
15 females which were administered the vehicle (vehicle
controls), and groups of 14 males and 16 females which
were untreated (untreated controls). All surviving mice
were killed at 83-85 weeks.
Mean bodyweights ofthe low-dose male rats, low- and
high-dose female rats, and low-dose male and female
mice were comparable to those of the untreated and
vehicle controls. The meanbodyweightsofthehigh-dose
male rats and thehigh-dose male and femalemice,which
died early, were lower than those ofthe controls.
Sarcoma of the abdominal cavity (peritoneum) was
found in dosed animals ofboth species, but did not occur
in either the untreated or vehicle controls. In male rats,
this lesion occurredwith a significant dose-related trend
(P>0.001), using avehicle controls, and also atsignificant
incidences in direct comparisons of the dosed groups
with the vehicle controls (controls 0/10, low-dose 11131,
P =0.027; high-dose 16/20, P<0.001). In female rats, the
lesionoccurred atasignificantincidenceinthehigh-dose
group compared with the vehicle controls (controls 0/9,
high-dose 16/30, P=0.004). None were observed among
low-dose females.
In the mice, sarcoma of the abdominal cavity (per-
itoneum) occurred at a high and statistically significant
incidence in the high-dose groups of each sex compared
withvehicle controls (males: controls 0/15, high-dose 17/21,
P<0.001; females: controls 0/13, high-dose16/20, P<0.001).
Nonewereobservedamonglow-dosegroups.Themorphol-
ogy ofthe sarcoma was similar in the rats and the mice.
It is concluded that under the conditions of this bio-
assay, phenoxybenzamine hydrochloride was car-
cinogenic (sarcomagenic) for the peritoneum of both
sexes ofSprague-Dawley rats and B6C3F1 mice.
Synonym: N-(2-chloroethyl)-N-(1-methyl-2-phenoxye-
thyl)benzylamine hydrochloride
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-73 Bioassay ofAllyl Chloride for
Possible Carcinogenicity (CAS No.
107-05-1)
Allyl chloride is an extremely useful chemical inter-
mediate since it can react both as an organic halide and
as an olefin. Most derivatives of allyl chloride do not
reach on end-use market themselves, but are part of
further syntheses. Important "first generation" deriva-
tives of allyl chloride include glycerol, epichlorohydrin,
and allyl alcohol. Other derivatives include medicinals,
such as barbiturates, diuretics, and herbicides.
A bioassay for possible carcinogenicity of technical-
grade allyl chloride was conducted using Osborne-Mendel
rats and B6C3F1 mice. At initiation ofthe study the rats
were approximately 6 weeks old and the mice approx-
imately 5 weeks old. Allyl chloride in corn oil was admin-
isteredbygavagetotwogroupsofeachspeciesfor5days a
weekfor78weeks, followedbyobservationperiods of30to
33weeks forthe rats and 14weeks forthe mice. The time-
weightedaveragedosageswere,respectively,77and57mg/
kg/day for high and low dose male rats; 73 and 55mg/kg!
dayfor high and low dose female rats; 199 and 172 mg/kg/
dayforhigh and low dose male mice; and 258 and 129mg/
kg/day for high and low dose female mice.
Foreachspecies,20animalsofeachsexwereplaced on
test as vehicle controls. These animals were intubated
with corn oil at the same time that dosed animals were
gavagedwith allylchloride in cornoil.Twentyanimals of
each sex were placed on test as untreated controls for
each species. These animals were not intubated.
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Survival ofhigh dose male mice and high dose rats of
both sexeswas extremelypoor. Fiftypercent ofthe high
dosemalemicewere deadbyweek27; the10members of
this group that survived pastweek 48 were sacrificed in
week 56. Among the high dose rats, 50 percent of the
males had died byweek 14 and 50 percent ofthe females
had died byweek 38. Because ofearlymortalityin these
groups, the number ofanimals surviving long enough to
be atrisk from late-developing tumorswas not adequate
formeaningful statistical analysis.
In this bioassay, squamous-cell carcinomas ofthe for-
estomach in male and female mice and squamous-cell
papillomas oftheforestomach infemalemiceoccurredin
incidences that were higher than in historical controls.
No other neoplasms occurred in statistically significant
increased incidences in dosed rats or mice
Under the conditions Of this bioassay no convincing
evidence was presented for the carcinogenicity of allyl
chloride in Osborne-Mendel rats of either sex. The
results are suggestive that allyl chloride is carcinogenic
in male and female B6C3F1 mice since the compound,
when administered by gavage caused a low incidence of
neoplastic and nonneoplastic lesions ofthe forestomach.
Synonyms: 3-chloro-1-propene; 3-chloropropene; chlo-
ropropylene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Equivocal
Female Mice: Equivocal
TR-74 Bioassay of1,1,2-frichloroethane
for Possible Carcinogenicity (CAS No.
79-00-5)
1,1,2-Tlichloroethane, an aliphatic chlorinated hydro-
carbon, isused as achemicalintermediatein theproduc-
tionofvinylidene chloride. Otherapplicationsinclude use
inadhesives,intheproductionofteflontubing,inlacquer,
and in coatingformulations, and as a solvent forfats, oil,
waxes, and other products.
Abioassayoftechnical-grade 1,1,2-trichloroethane for
possible carcinogenicity was conducted using Osborne-
Mendel rats and B6C3F1 mice. 1,1,2-Trichloroethane in
corn oil was administered by gavage, at either of two
dosages, to groups of 50 male and 50 female animals of
each species, 5 days a week for a period of 78 weeks,
followed by an observation period ofup to 35 weeks for
rats and up to 13 weeks for mice.
The high and low time-weighted average dosages of
1,1,2-trichloroethanewere,respectively, 92and46mg/kg/
dayformale andfemale rats, and 390 and 195mg/kg/day
forthe male and female mice.
Foreachspecies,20animalsofeach sexwereplaced on
test as vehicle controls. These animals were gavaged
with corn oil at the same rate as the high dose group of
the same sex. Twenty animals ofeach sexwereplaced on
test as untreated controls for each species. These ani-
mals were not intubated.
No neoplasms were observed at statistically signifi-
cant incidences in male or female rats.
In both male and female mice, administration of1,1,2-
trichloroethane was associated with a significantly
increased incidence of hepatocellular carcinomas.
Hepatocellular carcinomas were observed in 2/17 (12
percent) untreated control males, 2/20 (10 percent) vehi-
cle control males, 18/49 (37 percent) low dose males, and
37/49 (76 percent) high dose males. Hepatocellular car-
cinomas were also observed in 2/20 (10 percent) untre-
ated control females, 0/20 vehicle control females, 16/48
(33 percent) low dose females, and 40/45 (89 percent)
high dosefemales. Both the Fisherexacttestcomparing
tumor incidences of dosed to control groups and the
Cochran-Armitage test for positive dose-related trend
indicated a highly significant (P<0.001) association
between hepatocellular carcinomas in all mouse groups
and the administration of1,1,2-trichloroethane.
A positive dose-related association between admin-
istration of 1,1,2-trichloroethane and the incidence of
pheochromocytomaoftheadrenalglandwasindicatedby
theCochran-Armitage testformiceofbothsexes. Fisher
exact tests confirmed these results for high dose female
micebutnotforothermousegroups.Therewere noother
neoplasms forwhich statistical tests indicated apositive
association between dosage and tumorincidence inmice.
The results of this study do not provide convincing
evidence for the carcinogenicity of 1,1,2-trichloroethane
in Osborne-Mendel rats.
Under the conditions of this bioassay 1,1,2-trichlo-
roethane is carcinogenic in B6C3F1 mice, causing hepato
cellular carcinomas and adrenal pheochromocytomas.
Synonyms: vinyltrichloride; beta-trichloroethane
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Positive
Positive
TR-75 Bioassay of Chlorobenzilate for
Possible Carcinogenicity (CAS No.
510-15-6)
Chlorobenzilate is an agricultural pesticide used for
mite control on citrus crops. Additionally, it is effective
against mites in orchards, vineyards, tea plantations,
field crops, and ornamental plants. Since bees are not
severely affected by chlorobenzilate, it is also used to
control the tracheal mite ofthis insect.
A bioassay of technical-grade chlorobenzilate for
possible carcinogenicity was conducted using Osborne-
Mendel rats and B6C3F1 mice. Chlorobenzilate was
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administered inthe feed, ateitheroftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Chlorobenzilate was administered for 78 weeks
followed by an observation period of 12 or 13 additional
weeks in mice and 32 or 33 additional weeks in rats.
The time-weighted average dietary concentrations of
chlorobenzilate were 2,995 and 1,600 ppm for high and
lowdosemalerats, respectively, and2,229 and 1,175ppm
for high and low dose female rats. Mice received time-
weighted average high andlowdietaryconcentrations of
7,846 and 4,231 ppm, respectively, for males and 5,908
and 3,200 ppm, respectively, for females.
Survival in both species was high (over 68 percent of
the high dose rats and over 82 percent ofthe high dose
mice survived on test until the end ofthe study). Dose-
related mean body weight depression, observed in both
species, indicated that the maximum dose for optimal
bioassay sensitivity was used in the high dose groups.
An increased incidence of hepatocellular carcinomas
was observed in dosed mice, i.e., 4/19 (21 percent) in
controlmales, 32/48 (67percent) inlowdosemales,22/45
(49 percent) in high dose males, 0/20 in control females,
11/49 (22 percent) in low dose females, and 13/50 (26
percent) in high dose females.
There was a statistically significant positive associa-
tion between the administration of chlorobenzilate and
the appearance ofcortical adenoma ofthe adrenal gland
in low dose male and high dose female rats. Although
suggestive, the findings of a low incidence of benign
adrenal tumorswas notconsidered sufficient evidence to
establish the carcinogenicity of chlorobenzilate for the
Osborne-Mendel rat.
Under the conditions of this bioassay, orally admin-
istered chlorobenzilate was carcinogenic in male and
female B6C3F1 mice, causing an increased incidence of
hepatocellular carcinomas. The results do not, however,
provide sufficient evidence for the carcinogenicity of
chlorobenzilate in Osborne-Mendel rats.
Synonyms: 4,4'-dichlorobenzilic acid, ethyl ester; ethyl
4,4'-dichlorobenzilate
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Equivocal
Equivocal
Positive
Positive
TR-76 Bioassay of Tris (2,3-
Dibromopropyl) Phosphate for Possible
Carcinogenicity (CAS No. 126-72-7)
Tris (2,3-dibromopropyl) phosphate (TBP) is a com-
pound thathas beenwidelyused as aflame retardantfor
synthetic fabrics, particularlythose made into sleepwear
for infants and young children. In addition to its use by
the textile industry, TBP is also a fire retardant additive
for polystyrene and polyurethane foams, polyvinyl chlo-
ride and phenolic resins, intumescent and nonintumes-
cent paints, paper coatings, and rubber.
Abioassayoftechnical-gradetris (2,3-dibromopropyl)
phosphate (TBP) for possible carcinogenicity was con-
ducted using Fischer 344 rats and B6C3F1 mice. TBP
was administered inthefeed, ateitheroftwo concentra-
tions, to groups of 55 male and 55 female rats, and 50
male and 50 female mice. The high and low dietary
concentrations ofTBP administered were, respectively,
100 and 50 ppm for the male and female rats, and 1,000
and 500 ppm for the male and female mice. After a 103-
week dosing period, observation of the rats and mice
continuedfor1or2additionalweeks. Foreachspecies,55
animals of each sex were placed on test as controls. No
TBP was added to their diet.
In both species, adequate numbers of animals in all
groups survived sufficiently long to be at risk from late-
developing tumors.
Kidney tubular-cell adenomas were observed at inci-
dences which were significant for dosed rats of both
sexes by all statistical tests applied. For male rats there
was a significant positive association between the inci-
dence of kidney tubular-cell adenocarcinomas and
dietary concentration of TBP. Other neoplastic lesions
appearinginthetreatedratswerenotstatisticallysignif-
icant when compared with the control groups.
Among mice, a number of malignant and benign
tumors were associatedwith TBP administration. These
tumors included renal tubular-cell carcinoma and ade-
noma; squamous-cell papilloma and carcinoma of the
forestomach; hepatocellular carcinoma and adenoma;
and bronchiolar/alveolar adenoma and carcinoma.
Renal tubular-cell carcinomas were observed at a sta-
tistically significantincidence inmalemicebutnonewere
observed in females. Tubular-cell adenomas were
observed in treated mice of both sexes, but not in their
respective controls. The incidence of tubular-cell ade-
nomas was significant in male mice but not in females.
Squamous-cell carcinomas were observed in for-
estomachs ofmice ofboth sexes but not in their respec-
tivecontrols.Theincidencewassignificantinfemalesbut
notin males. Theincidences ofsquamous-cellpapillomas
oftheforestomachweresigniflcantinmice ofboth sexes.
Incidences ofhepatocellular carcinoma and hepatocellu-
lar adenoma were each significant in female mice. Tumor
incidence among male mice was not significant for
hepatocellular carcinomas or hepatocellular adenomas.
Theproportion ofmice ofeach sexhavingbronchiolar/
alveolar adenoma or carcinoma or both had a significant
positive dose-related trend. Theincidence ofbronchiolar/
alveolarcarcinomas exhibited asignificantpositive dose-
related trend for males, but not for females.
It is concluded that under the conditions ofthis study
orally administered TBP was carcinogenic to B6C3Fj
mice, causing increased incidences of tumors in livers,
lungs, and stomachsoffemalemiceandinkidneys,lungs,
and stomachs ofmalemice. TBPwas alsocarcinogenicin
Fischer 344 rats, causing an increased incidence of
kidney tumors in both sexes.
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Synonyms: 2,3-dibromo-1-propanol phosphate (3:1); tris
(dibromopropyl)phosphate; FiremasterT23P; This;TBP
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-77 Bioassay ofPyrimethamine for
Possible Carcinogenicity (CAS No. 58-14-0)
A bioassay of pyrimethamine, a prophylactic anti-
malarial, for possible carcinogenicity was conducted by
administering the test chemical in feed to Fischer 344
rats and B6C3F1 mice.
Groups of 35 rats and 35 mice of each sex were
administered pyrimethamine 5 days per week at one of
two doses, either 200 or 400 ppm for the rats and either
500 or 1,000 ppm for the mice. The animals were admin-
isteredthechemicalfor78weeks,thenobservedfor26or
27 additional weeks. Matched controls consisted of 15
untreated rats and 15untreated mice ofeach sex; pooled
controlsconsistedofthematchedcontrolscombinedwith
30 untreated rats and 30 untreated mice from similar
bioassays oftwoothertestcompounds.Allsurvivingrats
and mice were killed at 102-105 weeks.
Mean body weights of the rats and mice fed diets
containingpyrimethaminewereslightlylowerthanthose
of the matched controls. Survival of the rats was not
affected adversely by the chemical. In mice, survival
rates ofboth dosed and matched-control males were low,
with nearly two-thirds ofthe dosed and one-half of the
control mice dying byweek 52. Some ofthe deaths were
associated with respiratory infections and may not have
been related to administration ofthe chemical. Numbers
of animals at risk in the dosed and control groups of
femalemicewereadequate,however,forthedevelopment
oflate-appearing tumors.
In rats ofeach sex, no neoplastic lesions werefound at
a statistically significant incidence in the groups fed the
pyrimethamine as compared with control groups. An
increasedfrequencyofbone-marrowatrophyoccurredin
both male and female dosed groups.
In male mice, the markedly decreased life spans may
havepreventedtheobservationoflate-appearingtumors,
since only two tumors were observed, one in ahigh-dose
mouse and one in a low-dose mouse. In female mice, no
neoplastic lesions were found atastatisticallysignificant
incidence in the groups fed the pyrimethamine as com-
pared with control groups.
It is concluded that under the conditions of this bio-
assay, pyrimethamine was not carcinogenic for male or
female Fischer 344 rats or forfemale B6C3F1 mice. The
carcinogenic potential of pyrimethamine for male
B6C3F1 mice cannot be assessed by this bioassay,
because ofthe markedly reduced life span.
Synonym: 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidine-
diamine
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Inadequate Study
Female Mice: Negative
TR-78 Bioassay of ICRF-159 for Possible
Carcinogenicity (CAS No. 21416-87-5)
A bioassay of the experimental anticancer drug
ICRF-159 forpossible carcinogenicitywas conducted by
administering thecompoundbyintraperitonealinjection
to Sprague-Dawley rats and B6C3F1 mice.
Groups of 35 rats and 35 mice were injected three
timesperweekwithICRF-159inbufferedsalineatoneof
the following doses, either 48 or 96 mg/kg body weight
fortheratsandeither40or80mg/kgbodyweightforthe
mice. Both rats and mice were dosed for 52 weeks, then
observed for 29-34 additional weeks. Untreated-control
and vehicle-control groups each consisted of10 rats and
15 mice of each sex; pooled-control groups consisted of
the 10 vehicle controls of each sex of the rats combined
with 30 vehicle controls ofeach sex ofrats from similar
bioassays of three other chemicals and the 15 vehicle
controls ofeach sex ofthe mice combinedwith 30vehicle
controls ofeach sexofmicefromsimilarbioassays oftwo
other chemicals. All surviving rats were killed at 81-86
weeks; all surviving mice, at 86 weeks.
Mean body weights were depressed in rats and mice
administered ICRF-159, and mortality was dose related
among male and female rats and male mice. The high
mortalityamongthemaleratsmayhavebeenassociated
with inflammatory lesions observed in the lungs, the
liver, and the pleural and peritoneal cavities. Sufficient
numbers of female rats and of both male and female
mice were at risk for development of late-appearing
tumors. In the male rats, time-adjusted analysis of the
incidence oftumors was used for determining statistical
significance.
In female rats, the incidence of uterine adenocar-
cinomas was higher in the low- and high-dose groups
(P>0.001) than inthe pooled controls (controls 0/38, low-
dose 10/33, high-dose 11132); the incidence was also dose
related(P<0.001).
In male rats, no tumors occurred in the dosed groups
in a significantly increased incidence.
In female mice, the incidence of all hematopoietic
neoplasms (histiocytic lymphomas, lymphocytic lym-
phomas, or lymphocytic leukemias), taken together, was
higher in the low-dose group (P =0.038) and in the high-
dose group (P =0.002) than in the pooled controls (con-
trols 1/45, low-dose 5/31, high-dose 9/34); the incidence
was also dose related (P =0.002). In addition, the inci-
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dence ofthese tumors inthehigh-dose groupwas higher
(P=0.026)thanthatinthevehicle controls (0/15), andthe
incidence was dose related (P=0.021) using the vehicle
controls. In male mice, lymphocytic neoplasms occurred
only in two low-dose and two high-dose animals.
It is concluded that under the conditions of this bio-
assay, ICRF-159 was carcinogenic for female Sprague-
Dawley rats, producing uterine adenocarcinomas, and
was also carcinogenic for female B6C3F1 mice, produc-
ing lymphomas.
Synonyms: (± +)bis-4,4'-(1-methyl-1,2-ethanediyl)-2,6-
piperazinedione
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Negative
Female Mice: Positive
TR-79 Dulcin (CAS: 150-69-6)
Datafromthis studyconsidered tobeinconclusive and
not reportable; no Technical Report issued.
TR-80 Bioassay of1,4-Dioxane for
Possible Carcinogenicity (CAS No. 123-91-1)
1,4-Dioxane, a dimer ofethylene oxide, is used exten-
sively as an industrial solvent for lacquers, varnishes,
paints, plastics, dyes, oils, waxes, resins, and cellulose
acetate and as an inhibitor in chlorinated solvents. In
biological and chemicallaboratories, dioxane isemployed
as a solvent for tissue processing, liquid scintillation
counting, and photochemical reactions.
A bioassay of 1,4-dioxane for possible carcinogenicity
was conducted by administering the test chemical in the
drinkingwaterto Osborne-Mendel rats andB6C3F1 mice.
Groups of35 rats and 50 mice ofeach sex were admin-
istered1,4-dioxane atconcentrations ofeither0.5% to 1.0%
(v/v) in the drinking water. Because of variations in the
intake ofwater, the doses oftest chemical received by the
high-dose groups were not precisely twice those received
bythelow-dosegroups;inthemalemice,thehighdosewas
only slightly greater than the low dose. The rats were
dosed for 110 weeks and the mice for 90 weeks. Matched
controls consisted of 35 untreated rats and 50 untreated
mice of each sex. All surviving rats were killed at 110-117
weeks and all surviving mice at 90-93-weeks.
The mean bodyweights ofthe rats and mice were not
consistently affected by the administration of dioxane.
Survival rates of the dosed groups of rats and female
mice were lower than those of corresponding control
groups,butsufficientnumbers ofanimalswere atriskfor
development oflate-appearing tumors.
Inrats, theincidence ofsquamous-cell carcinomas ofthe
nasal turbinates was statistically significant in tests for
dose-related trend in females (P=0.008) and for direct
comparison of high-dose with matched-control males
(P<0.001) and direct comparison of dosed with control
females (P.0.003) (males: controls 0/33, low-dose 12(33,
high-dose 16/34; females: controls 0/34, low-dose 10/35,
high-dose 8/35). In the females, but not in the males, the
incidence of hepatocellular adenomas was significant
(P.0.001) in tests for dose-related trend and for direct
comparisonofbothlow-andhigh-dosegroupswithcontrols
(controls 0/31, low-dose 10/33, high-dose 1132).
In both male and female mice, the incidence of
hepatocellular-carcinomas was statistically significant
(P.0.001), bothintestsfordose-related trend and direct
comparison of both dosed groups with controls (males:
controls 2/49, low-dose 18/50, high-dose 24/47; females:
controls 0/50, low-dose 12/48, high-dose 29/37). The inci-
dences remained significant when hepatocellular ade-
nomas were combined with hepatocellular carcinomas.
It is concluded that under the conditions of this bio-
assay, 1,4-dioxane induced hepatocellular adenomas in
female Osborne-Mendel rats. 1,4-Dioxane was car-
cinogenic in both sexes ofrats, producing squamous-cell
carcinomas ofthe nasal turbinates, and in both sexes of
B6C3F1 mice, producing hepatocellular carcinomas.
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-81 Bioassay oflfimethylphosphate
for Possible Carcinogenicity (CAS No.
512-56-1)
Trimethylphosphate is an alkylating agent which has
beenused as agasoline additive, amethylatingagent, an
intermediate for the production of polymethyl phos-
phates, and a flame retardant in polymers.
A bioassay of trimethylphosphate for possible car-
cinogenicity was conducted by administering the com-
pound by gavage to Fischer 344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administeredtrimethylphosphateindistilledwaterthree
timesperweekatoneoftwodoses,either50or100mg/kg
body weight for the rats and either 250 or 500 mg/kg
body weight for the mice. Vehicle controls consisted of
groups of20 rats and 20 mice ofeach sex. The rats were
dosed for 104 weeks and the mice for 103 weeks. All
surviving rats were killed at week 105 and all surviving
mice atweek 103.
Meanbodyweights ofdosedmale andfemale rats and
femalemicewere slightlylowerthanthose ofthe corres-
ponding vehicle controls throughout the study; mean
bodyweights ofthemalemicewere comparable to those
of the vehicle controls. Survival rates of both rats and
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mice were high, and adequate numbers ofanimals were
at risk for the development oflate-appearing tumors.
In male rats, the incidence of fibromas of the sub-
cutaneous tissue was higher (P=0.036) in the high-dose
group than in the vehicle controls (control 0/20, low-dose
2/50, high-dose 9/49), and therewas a dose-related trend
(P=0.006) in the incidences of these fibromas. In the
female rats, no tumors occurred in the dosed groups at
significantlyincreasedincidences, comparedwithcorres-
ponding controls.
In the male mice, no tumors occurred in the dosed
groups at significantly increased incidences, compared
with controls. In the female mice, the incidence of ade-
nocarcinomas oftheendometriumwashigher (P=0.004)
in the high-dose group than in the vehicle controls (con-
trols 0/16, low-dose 7/40, high-dose 13/37), and there was
a significant dose-related trend (P= 0.003) in the inci-
dences ofthese adenocarcinomas.
It is concluded that under conditions ofthis bioassay,
trimethylphosphate was carcinogenic in female B6C3F1
mice, inducing adenocarcinomas of the uterus/
endometrium. Trimethylphosphate was associated with
the induction of benign fibromas of the subcutaneous
tissue in male Fischer 344 rats. No evidence of car-
cinogenicityofthecompound was obtainedinfemalerats
orin male mice.
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Negative
Negative
Positive
TR-82 Bioassay of N-Phenyl-
p-phenylenediamine for Possible
Carcinogenicity (CAS No.101-54-2)
N-phenyl-p-phenylenediamine is an industrial inter-
mediate that is used in the production ofseveral different
chemical products. It is an intermediate for photographic
chemicals, pharmaceuticals, microbicides, andotherorgan-
ics; itisusedinthemanufacture ofdyes and dyereagents;
and it reacts with ketones to form derivatives of p-phe-
nylenediamine which are used as antiozonants in rubber.
A bioassay of N-phenyl-p-phenylenediamine for
possible carcinogenicity was conducted by administer-
ing the test chemical in the diet to Fischer 344 rats and
B6C3F1 mice.
Groups of 50 rats of each sex were administered N-
phenyl-p-phenylenediamine at one of two doses, either
600 or 1,200 ppm, for 78 weeks and were then observed
for 26 additional weeks. Matched controls consisted of
groups of20untreated ratsofeach sex.Allsurvivingrats
were killed at 104 weeks.
Groups of 50 mice of each sex were initially admin-
istered N-phenyl-p-phenylenediamine at one of the fol-
lowingdoses, either2,500 or5,000ppmforthemales and
either 5,000 or 10,000 ppm for the females, for 31 weeks.
Because of toxicity of the chemical, the doses were
lowered at that time and terminated at 48 weeks. The
animals were then observed for 43 additional weeks.
Time-weighted average doses during the period of
administrationwere2,057 or4,114ppmforthemales and
3,672or8,170forthefemales.Matchedcontrolsconsisted
ofgroups of20 untreated mice ofeach sex. All surviving
mice were killed at 91 weeks.
Meanbodyweightsofthedosedratswereonlyslightly
lower than those of the matched controls during the
bioassay. Mean body weights of the dosed mice were
appreciably lower than those of the matched controls,
and mortality was high in the dosed groups prior to the
reduction ofthe doses, particularly in the females. Suffi-
cientnumbers ofratsandmiceofeachsexwereatriskfor
the development oflate-appearing tumors; however, the
shortened period used for administering N-phenyl-
p-phenylenediamine to the mice may not have been ade-
quate for determining the carcinogenic potential of the
test chemical in this species.
In the male and female rats, the incidences of neo-
plasmsinthegroupsreceivingthetestchemicalwerenot
significantly different from those in the corresponding
control groups.
In the male mice, the incidence of combined hepato-
cellular adenomas and carcinomas was significantly
higher (P= 0.022) in the low-dose group than in the
controls, but there was no significant dose-related trend
(controls 2/20, low-dose 18/49, high-dose 10/50). Further-
more, since at this laboratory the overall historical inci-
dences ofthese combined lesions in male mice have been
53/340 (15.6%) andhavebeen ashigh as7/20(35%),these
neoplasms could not be established as being compound
related. Unusually extensive hepatic inflammation
occurred in large numbers ofthe dosed males (controls
0/20, low-dose 23/49, high-dose24/50) and in lesser num-
bers of the dosed females (controls 1120, low-dose 8/49,
high-dose 2/48).
It is concluded that under the conditions of this bio-
assay, N-phenyl-p-phenylenediamine was not car-
cinogenic for Fischer 344 rats or for B6C3F1 mice.
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-83 Bioassay ofDaminozide for
Possible Carcinogenicity (CAS No.
1596-84-5)
Abioassayofdaminozide, aplantgrowthregulator, for
possiblecarcinogenicitywasconductedbyadministering
the test chemical in the diet to Fischer 344 rats and
B6C3F1 mice.
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Groups of 50 rats and 50 mice of each sex were
administered daminozide atoneoftwodoses,either5,000
or 10,000 ppm, for 104 weeks, then observed for an
additionalweek. Matched controls consisted of20 untre-
ated males and 20 untreated females ofeach species. All
surviving rats and mice were killed at 105 weeks.
Mean bodyweights ofthe high-dose female micewere
appreciably lower than those of the corresponding con-
trols, while mean bodyweights ofall other dosed groups
of rats and mice were essentially unaffected. No other
clinical signs related to administration of daminozide
were observed. Sufficient numbers of animals in all
groups ofrats and mice were at risk for development of
late-appearing tumors.
Inthemalerats, notumors occurred atincidencesthat
were significantly higher in dosed groups than in con-
trols, except for interstitial-cell tumors of the testis
(controls 13/20, low-dose 49/50, high-dose 47/50). These
tumors occurred, however, at a high spontaneous rate
(182/220) in the historical-control male rats; thus, the
association of the interstitial-cell tumors with admin-
istration ofthe chemical is doubtful.
In the female rats, adenocarcinomas of the
endometrium and leiomyosarcomas of the uterus
occurred only in the dosed groups (adenocarcinomas:
controls 0/19, low-dose 5/50, high-dose 3/50; leiomyosar-
comas: controls 0/19, low-dose 1150, high-dose 3/50). The
incidences in the dosed groups were too low to be statis-
tically significant; however, the low incidence of these
tumors in historical-control female rats (2/220 adenocar-
cinoma and 0/220 leiomyosarcoma) indicate that the
occurrence ofthese tumors in the dosed female rats was
associated with the administration ofdaminozide.
In the male mice, there was a dose-related trend
(P =0.008) in theincidence ofhepatocellular carcinomas;
also, theincidence inthehigh-dose groupwas significant
(P =0.020) compared with that in the controls (controls
0/14, low-dose 7/50, high-dose 13/46). The incidence of
these tumors in the historical-control male mice was,
however, 211216; thus, the association ofthe hepatocellu-
lar carcinomas with administration ofdaminozide is not
clear. In female mice, only three such tumors occurred.
Itis concluded thatunderthe conditions ofthisbioassay,
daminozide was not carcinogenic in the male Fischer 344
rats or in the female B6C3F1 mice. In male B6C3F1 mice,
the induction ofhepatocellular carcinomas may have been
associated with the administration of the test chemical.
Daminozide was carcinogenic in female Fischer 344 rats,
inducing adenocarcinomas of the endometrium of the
uterus and leiomyosarcomas ofthe uterus.
Synonym: succinic acid mono-2,2-dimethylhydrazide
Report Date: 1978
Levels of Evidence ofCarcinogenicity:
TR-84 Bioassay of 2,4-Diaminoanisole
Sulfate for Possible Carcinogenicity (CAS
No.615-05-4)*
2,4-Diaminoanisole sulfate, a component ofmany hair
dyes, was selected for bioassay by the National Cancer
Institute because of the increased incidence of bladder
cancer observed amongworkers in the dye manufactur-
ing industry.
A bioassay of technical-grade 2,4-diaminoanisole sul-
fate for possible carcinogenicity was conducted using
Fischer 344 rats and B6C3F1 mice. 2,4-Diaminoanisole
sulfate was administered in the feed, at either of two
concentrations, to groups of 50 male and 50 female
animals of each species. The time-weighted average
dietaryconcentrationsused inthe chronicbioassaywere
0.12 percent forthe low dose rats and 0.5 percent for the
high dose rats. The dietary concentrations used for low
and high dose mice were 0.12 and 0.24 percent, respec-
tively.Aftera78-weekperiod ofchemicaladministration,
observation of the rats continued for an additional 29
weeks and observation of the mice continued for an
additional 19weeks. Foreach species, 49 or 50 animals of
each sex were placed on test as controls.
In both species, adequate numbers of animals in all
groups survived long enough to be at risk from late-
developing tumors.
In high dose male and female rats groups, the propor-
tion of animals having one or more of the following
malignant follicular-cell thyroid tumors: papillary ade-
nocarcinomas, follicular-cell carcinomas, papillary
cystadenocarcinomas, or adenocarcinomas NOS, was
significantly greater than the proportion in correspond-
ing control groups. For high dose male rats the propor-
tion ofanimals havingeither aC-cell adenoma ora C-cell
carcinoma was also significantly increased.
The incidence of malignant tumors (squamous-cell
carcinomas, basal-cell carcinomas, or sebaceous ade-
nocarcinomas) ofthe skin and its associated glandswere
significantly increased among high dose rats of both
sexes.
Among high dose female mice, the combined incidence
of thyroid follicular-cell adenomas and carcinomas was
significantly increased. Among high dose male mice, the
incidence ofthyroid follicular-cell adenomas was signifi-
cantly increased, but no follicular-cell carcinomas were
observed.
Under the conditions ofthis bioassay, technical-grade
2,4-diaminoanisole sulfate was carcinogenic to both
sexes ofboth species. In Fischer 344 rats dietary admin-
istration ofthe chemical induced increased incidences of
malignant tumors of the skin and its associated glands
and malignant thyroid tumors in each sex. In B6C3Fj
mice, dietary administration of 2,4-diaminoanisole sul-
fate induced thyroid tumors in each sex.
Synonyms: 4-methoxy-1,3-benzenediamine sulfate;
4-methoxy-m-phenylenediamine sulfate; 4-MMPD; 2,4-
diamino-1-methoxybenzene sulfate; 2,4-DAA sulfate
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Positive
Equivocal
Negative
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Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Positive
Positive
*The technical report states that 2,4-Diaminoanisole
Sulfate (CAS No. 39156-41-7) was the actual chemical
tested rather than 2,4-Diaminoanisole in its pure form;
therefore, the CAS number for 2,4-Diaminoanisole Sul-
fate is used to track this study in the NTP CHEM-
TRACK database.
TR-85 Bioassay of4-Chloro-
m-phenylenediamine for Possible
Carcinogenicity (CASNo. 5131-60-2)
4-Chloro-m-phenylenediamine, an intermediate in the
preparation of dyes, was selected for bioassay by the
National Cancer Institute because ofthe high incidence
of bladder cancer reported among workers in the dye
manufacturing industry.
A bioassay of 4-chloro-m-phenylenediamine for
possible carcinogenicity was conducted using Fischer
344 rats and B6C3F1 mice. 4-Chloro-m-phenylene-
diamine was administered in the feed, at either of two
concentrations, to groups of49 or 50 male and 50 female
animals of each species. The dietary concentrations of
4-chloro-m-phenylediamine used in the chronic bioassay
for low and high dose rats were 0.2 and 0.4 percent,
respectively. The time-weighted average dietary con-
centrations used forlowandhigh dose mice were 0.7 and
1.4 percent, respectively. After a 78-week period of com-
pound administration, observation ofthe rats continued
for anadditional17weeks. Foreach species,50animalsof
each sex were placed on test as untreated controls.
In both species, adequate numbers of animals in all
groups survived long enough to be at risk from late-
developing tumors.
Among male rats, an increased incidence of adrenal
pheochromocytomas was statistically associated with
dosage of 4-chloro-m-phenylenediamine. The incidence
ofthese tumors was significantlyhigherin the high dose
group than in the control group.
Among female mice, there was a significant increased
incidence of hepatocellular carcinomas in the low dose
group and a significantly combined incidence of
hepatocellular carcinomas and hepatocellular adenomas
inbothlowandhighdose groups ascomparedtocontrols.
No other neoplasms in either species were considered
to be related to compound administration.
Under the conditions of this bioassay, dietary admin-
istration of 4-chloro-m-phenylenediamine was car-
cinogenic to the experimental animals, causing an
increased incidence of hepatocellular tumors in female
B6C3F1 mice and an increased incidence of adrenal
pheochromocytomas in male Fischer 344 rats.
Synonyms: 4-chloro-1,3-benzenediamine; 4-chloro-
phene-1,3-diamine; 4-chloro-1,3-phenylenediamine; C.I.
76027
Report Date: 1978
Levels ofEvidence of-Carcinogenicity:
Male Rats: Positive
Female Rats: Negative
Male Mice: Negative
Female Mice: Positive
TR-86 Bioassay of1,2-Dibromoethane for
Possible Carcinogenicity (CAS No.
106-93-4)
1,2-Dibromoethane, a volatile saturated brominated
hydrocarbon, is used principally as a lead scavenger in
tetra-alkyl leadgasoline and antiknockpreparationsbut
also as a soil and grain fumigant, a chemical intermedi-
ate, and a solvent.
A bioassay for possible carcinogenicity of technical-
grade 1,2-dibromoethane was conducted using Osborne-
Mendel rats and B6C3F1 mice. 1,2-Dibromoethane in
corn oil was administered by gavage, at either of two
dosages, to groups of 50 male and 50 female animals of
each species. The time-weighted average high and low
doses of1,2-dibromoethane used in the chronic bioassay
were, respectively, 41 and 38 mg/kg/dayformale rats, 39
and 37mg/kg/dayfor female rats and 107 and 62 mg/kg/
dayformiceofboth sexes. Foreachspecies 20 animals of
each sex were placed on test as vehicle controls. These
animals were gavaged with corn oil with the same fre-
quency that dosed animals were gavaged with 1,2-
dibromoethane mixtures. Twenty animals of each sex
were placed on test as untreated controls for each spe-
cies. These animals were not intubated.
There was a positive association between increased
dosageandacceleratedmortalityinratsandmiceofboth
sexes. All surviving dosed male rats were sacrificed in
week 49 and all surviving dosed female rats were sacri-
ficed after 61 weeks of compound administration. All
male mice and high dose female mice died or were
sacrificed by week 78, while the low dose mice were
observed for an additional 37 weeks after a 53-week
period ofchemical administration.
In rats squamous-cell carcinomas of the forestomach
were observed in45/50, 33/50,40/50 and29/50 ofthe low
dose males, high dose males, low dose females and high
dose females, respectively, while none were observed in
controls. Eachoftheseincidenceswasstatisticallysignif-
icant. These lesionswere seen as early asweek 12 in rats
andweek 24 in mice; theyinvaded locally and eventually
metastasized. Increasedincidencesofhepatocellularcar-
cinomaswereobservedindosedrats,buttheincidenceof
this neoplasm was significant onlyin females. Increased
incidences ofhemangiosarcomas were observed in each
dosed rat group, but was statistically significant only in
males, where they appeared as early as week 26.
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Earlydevelopment ofsquamous-cell carcinomaswhich
invaded and metastasized was also observed among
mice. Squamous-cell carcinomas were found in 45/50,
29/49, 46/49 and 28/50 ofthe low dose males, high dose
males, low dose females, and high dose females, respec-
tively, but none were found in controls. Each of these
incidences was statistically significant. Incidences of
alveolar/bronchiolar adenomas were significant for male
and female dosed mice.
Under the conditions of this bioassay, 1,2-dibro-
moethane was carcinogenic to Osborne-Mendel rats and
B6C3F1 mice. The compoundinduced squamous-cell car-
cinomas of the forestomach in rats of both sexes,
hepatocellular carcinomas in female rats, and
hemangiosarcomasinmalerats. Inmiceofbothsexesthe
compound induced squamous-cell carcinomas ofthe for-
estomach and alveolar/bronchiolar adenomas.
Synonyms: DBE; sym-dibromoethane; ethylene dibro-
mide; EDB; glycol dibromide
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
Note: 1,2-dibromoethane was subsequently studied by
inhalation in F344 rats and B6C3F1 mice (See TR-210,
reported 1982).
TR-87 1,3-Dichloro-5,5-
Dimethylhydantoin (Ethylene Dibromide)
(CAS: 118-52-5)
Datafromthis studyconsideredtobeinconclusive and
not reportable; no Technical Report issued.
TR-88 Bioassay of1H-Benzotriazole for
Possible Carcinogenicity (CAS No. 95-14-7)
1H-Benzotriazole is an anticorrosive chemical used
primarily on copper, but also on iron, steel, cadmium,
chromium, zinc, and silver-nickel alloys.
A bioassay of 1H-benzotriazole for possible car-
cinogenicity was conducted by administering the test
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of 50 rats of each sex were administered 1H-
benzotriazole atone oftwotime-weighted averagedoses,
either 6,700 or 12,100 ppm, for 78 weeks. Except for five
control and five high-dose rats of each sex, which were
killed atweek 78, all animals surviving atthattimewere
observed for 26-27 additional weeks. Controls consisted
of groups of 50 untreated rats of each sex and were
observed for 105-106 weeks. All rats surviving to weeks
104-106 were then killed.
Groups of50 mice of each sex were administered 1H-
benzotriazole atone oftwotime-weighted average doses,
either11,700 or23,500 ppm, for104weeks, then observed
for2 additionalweeks. Controls consisted ofgroups of50
untreated mice of each sex and were observed for 109
weeks. All mice surviving to weeks 106-109 were then
killed.
Mean bodyweights ofthe dosed male and female rats
and mice were lower than those of the corresponding
controls throughout most of the bioassay. Survival of
animalsindosedandcontrolgroupsofbothratsandmice
was atleast60%, andsufficientnumbers ofanimalswere
at risk for development oflate-appearing tumors.
Inmalerats,neoplasticnodulesoftheliveroccurredat
a statistically significant incidence (P= 0.024) in the
high-dose group when compared with the control group
(controls 0/48, low-dose 0/46, high-dose 5/45 [11%]). The
incidenceofthistumorincontrol Fischer344ratsusedin
similar bioassays of other test chemicals at the same
laboratory hasvaried from 0 to 11%,with 2/13 historical-
control groups having incidences of 10-11%. Since the
incidence in the high-dose groups is no higher than has
been observed in some control groups, these tumors
cannot be clearly associated with administration of the
test chemical.
Braintumorsoccurredinthreedosedmalerats,in one
dosed female rat, and in none ofthe controls. The occur-
rence ofthis rare tumor in dosed animals ofeach sex is
suggestiveof,butnotconsideredassufficientevidenceof,
carcinogenicity.
In female rats, the incidence of endometrial stromal
polyps in the low-dose group was significantly higher
(P=0.010) than that in the corresponding controls (con-
trols 2/48, low-dose 10/45, high-dose 8/50). However, the
incidence inthehigh-dose groupwas notsignificant, and
when the incidences of endometrial stomal polyps and
endometrial stromal sarcomaswerecombined,theywere
not significant in either the low- or high-dose groups.
Thus, these tumors cannot be associated with admin-
istration ofthe chemical.
In male mice, no tumors occurred in dosed groups at
incidences that were significantly higher than those in
controls.
In female mice, alveolar/bronchiolar carcinomas
occurred at a statistically significant incidence
(P=0.001) only in the low-dose groups when compared
with the control group (controls 0/49, low-dose 9/49
[18%], high-dose 3/59 [6%]). The incidence in the high-
dosegroupwas notsignificant, andthe datadid notshow
adose-relatedtrend. Itshouldbenotedthattheincidence
of these tumors in control B6C3F1 female mice from
other bioassays at this laboratory has varied from 0 to
7%,with amean of4%. Therefore, the occurrence ofthis
tumor in female mice cannot be clearly related to the
administration ofthe test chemical.
In female B6C3F1 mice there was an increased inci-
dence of alveolar/bronchiolar carcinomas, suggesting a
possible carcinogenic effect of 1H-benzotriazole. In
Fischer 344 rats there was an increased incidence of
brain tumors, suggesting a possible carcinogenic effect.
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However, there was no convincing evidence that under
the conditions of this bioassay 1H-benzotriazole was
carcinogenic in B6C3F1 mice or Fischer 344 rats of
either sex.
Synonym: 1,2,3-benzotriazole
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Equivocal
Female Rats: Equivocal
Male Mice: Negative
Female Mice: Equivocal
TR-89 Bioassay ofo-Anisidine
Hydrochloride for Possible Carcinogenicity
(CASNo.134-29-0)
o-Anisidine is used chiefly in the manufacture ofdyes,
one method being the diazotization of o-anisidine and
couplingwith otheraromatic amines orphenols toyield a
large number ofthe azo dyes.
A bioassay of o-anisidine hydrochloride for possible
carcinogenicity was conductedbyadministering thetest
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of55 rats ofeach sex and 55 mice ofeach sex
were administered o-anisidine hydrochloride at one of
the following doses, either 5,000 or 10,000 ppm for rats
and either 2,500 or 5,000 ppm for mice, for 103 weeks,
then observed for 1 or 2 additional weeks. Controls
consisted ofgroups of55 untreated rats ofeach sex and
55 untreated mice of each sex. All surviving rats were
killed at 103-107 weeks, and all surviving mice at 104 or
105weeks.
Mean bodyweights ofthe dosed male and female rats
and mice were lower than those of the corresponding
controls throughout the bioassay. Bloody exudates and
stained fur in the urogenital area were noted in many
dosed animals. Sufficient numbers of animals were at
risk in the mice, but not in the rats, for development of
late-appearing tumors; however, survival in the rats was
80% or more at week 52.
Transitional-cell carcinomas or papillomas of the uri-
nary bladder occurred at statistically significant inci-
dences(P<0.001)inthelow-andhigh-dosegroupsofrats
(males: controls 0/51, low-dose 52/54, high-dose 52/52;
females: controls 0/49, low-dose 1151, high-dose 22/50);
the incidences also had significant dose-related trends
(P<0.001)inbothspecies.Theselesionswereobservedas
early asweek36infemalerats,week40inmalerats, and
week45inmalemice. Transitional-cell carcinomas ofthe
pelvis of the kidney occurred with a significant dose-
related trend (P =0.005) in the male rats, and the inci-
dence in the high-dose group was significantly higher
(P =0.006) than that in the control group (controls 0/53,
low-dose 3/55, high-dose 7/53); all ratshavingthis tumor
also has a transitional-cell carcinoma of the urinary
bladder. Only one animal in the control groups ofrats or
mice had any tumor of the urinary system (a
transitional-cell papilloma ofthe pelvis ofthe kidneyin a
male mouse).
Follicular-cell tumors of the thyroid (carcinomas,
cystadenocarcinomas, adenomas, cystadenomas, and
papillary cystadenomas) occurred atstatistically signifi-
cantincidences (P< 0.005) in low- and high-dose groups
of male rats (controls 0/53, low-dose 7/40, high-dose
6/40); the incidences also had a dose-related trend
(P= 0.009). These tumors did not occur at significant
incidences in dosed groups offemale rats.
It is concluded that under the conditions of this bio-
assay, o-anisidine hydrochloride was carcinogenic for
Fischer 344 rats and B6C3F1 mice, inducing
transitional-cell carcinomas orpapillomas ofthe bladder
in both rats and mice and in both sexes of each species,
transitional-cell carcinomas ofthepelvis ofthe kidneyin
malerats,andfollicular-celltumorsofthethyroidinmale
rats.
Synonyms: 2-methoxyaniline; Fast Red BB Base
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Positive
Positive
TR-90 Bioassay ofDicofol for Possible
Carcinogenicity (CAS No.115-32-2)
Dicofol, a synthetic organochlorine acaricide, was
selected for bioassay by the National Cancer Institute
because it is an alcohol analog of the known tumorigen
DDT. Its widespread use on edible crops was also an
important factor in its selection for testing.
Abioassay oftechnical-grade dicofol for possible car-
cinogenicity was conducted using Osborne-Mendel rats
and B6C3F1 mice. Dicofol was administered in the feed,
ateitheroftwoconcentrations, to groups of50males and
50 females of each species. The high and low time-
weighted average concentrations ofdicofolwere, respec-
tively, 942and471ppmformalerats, 760and380ppmfor
female rats, 528 and 264 ppm formalemice, and 243 and
122 ppm forfemale mice. For each species, 20 animals of
each sex were placed on test as controls. The period of
compound administration was 78 weeks, followed by 34
weeks of observation in rats and 14 or 15 weeks in
mice.
There was no statistically significant positive associa-
tion between dietary concentration and mortality in
either sex or species.
Hepatocellular carcinomas in dosed male mice were
the only neoplasms that occurred in any dosed group of
either species in statistically signiflcant increased inci-
dences when compared to controls. The Cochran-
Armitage test as well as the Fischer exact test for both
the high and low dose groups supported the association
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between compound administration and increased inci-
dences of this tumor in the male mice. No increase in
hepatocellular carcinomas was observed in dosed female
mice.
Under the conditions ofthis bioassay, technical-grade
dicofol was carcinogenic in male B6C3F1 mice, causing
hepatocellular carcinomas. No evidence for car-
cinogenicitywas obtainedforthis compoundin Osborne-
Mendel rats ofeither sex or in female B6C3F1 mice.
Synonyms:4-chloro-a-(4-chlorophenyl)-a-(trichloro-
methyl)benzenemethanol; 1,1-bis(p-chlorophenyl)- 2,2,2-
trichloroethanol; 4,4'-dichloro-a-trichloromethyl) ben-
zhydrol; 2,2,2-trichloro-1,1-di-(4-chlorophenyl) ethanol
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-91 Bioassay of Clonitralid for
Possible Carcinogenicity (CAS No.
1420-04-8)
occurrence in high dose female rats (2/45) ofcarcinomas
in the glandular portion ofthe stomach with metastases
to other sites was not statistically significant. This inci-
dence, however, is much greater than the historical con-
trol incidence and suggests an association between
administration of clonitralid and the development of
these tumors.
No statistically significantincreased tumorincidences
were observed among male rats or mice of either sex
dosed with clonitralid.
Under the conditions of this bioassay, there was no
convincing evidence that clonitralid was carcinogenic to
Osborne-Mendel rats or to female B6C3F1 mice. Poor
survival of male mice did not permit an evaluation of
carcinogenicity in these animals.
Synonyms: 5-chloro-N-(2-chloro-4-nitrophenyl)-2-
hydroxybenzamide compound with 2-aminoethanol (1:1);
Clonitralide; Bayer 25648; Bayer 73; SR 73
Report Date: 1978
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Equivocal
Inadequate Study
Negative
Clonitralid, apowerfulmolluscicide andlampreykiller,
was selected for bioassay by the National Cancer
Institute because of the large potential for human
exposure resulting from the direct application of the
compound forcontrol ofsealampreylarvaeintributaries
to the Great Lakes and the widespread application of
clonitralid for the control ofwater snails.
A bioassay for possible carcinogenicity of clonitralid
was conducted using Osborne-Mendel rats and B6C3F1
mice. Clonitralid was administered in the feed, at either
oftwoconcentrations, togroups of50male and 50female
animals ofeach species. Twenty animals ofeach sex and
species were placed on test as controls. The time-
weighted average high and lowdietary concentrations of
clonitralid were, respectively, 28,433 and 14,216 ppm for
rats and 549 and 274 ppm for mice. After a 78-week
period of compound administration, there was an addi-
tionalobservationperiodof32to33weeksforrats and13
to 14 weeks for mice.
Adequate numbers of male rats, female rats, and
female mice survivedlongenough tobe atriskfromlate-
developing tumors. Because of inadequate survival
among male mice, however, results obtained from obser-
vation of the male mouse groups cannot be considered
conclusive.
The incidences of mammary adenocarcinomas in
treatedfemaleratswerenotsignificantlyhigherthanthe
incidences observed in control female rats. However, the
incidences ofthislesionindosedfemaleratsweregreater
than or equal to 22 percent, while the highest incidence
observed in 15 control groups atthis laboratorywas only
10 percent with a mean incidence of 2.6 percent. The
TR-92 Bioassay ofHydrazobenzene for
Possible Carcinogenicity (CAS No.
122-66-7)
Hydrazobenzene is ahydrazine derivative selected for
bioassaybythe National Cancer Institutebecause ofthe
documented carcinogenicity of the parent compound
hydrazine and of certain substituted hydrazines. Treat-
ment ofhydrazobenzene with hot mineral acid results in
the production of benzidine (the so-called "benzidine
rearrangement") and hydrazobenzene finds application
in the dyemanufacturing industry as aprecursor ofthis
important dye intermediate and potent carcinogen.
A bioassay of technical-grade hydrazobenzene for
possible carcinogenicity was conducted using Fischer
344 rats andB6C3F, mice. Hydrazobenzene was admin-
istered in the feed, at either of two concentrations, to
groups of50 male and 47 to 50 females animals ofeach
species. The time-weighted average dietary concentra-
tionsused intheratbioassaywere 0.008, 0.03, 0.004, and
0.01percentforlowdosemales,highdosemales,lowdose
females, and high dose females, respectively. The time-
weighted average dietary concentrations used in the
mouse bioassaywere 0.008, 0.04, 0.004, and 0.04 percent
for low dose males, high dose males, low dose females,
and high dose females, respectively. After a 78-week
period of compound administration, observation of the
rats continued for an additional 28 to 30 weeks and
observation ofthe mice continued for an additional 17 or
18 weeks. For each species, 47 to 50 animals ofeach sex
were placed on test as controls.
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In both, species, adequate numbers of animals in all
groups survived sufficiently long to be at risk from late-
appearing tumors.
Theincidence ofhepatocellular carcinomas was signif-
icantlyincreased in dosed male rats and the incidence of
neoplasticnodulesoftheliverwassignificantlyincreased
in dosed female rats. A significant increase in the com-
bined incidence of squamous-cell carcinomas or
squamous-cell papillomas ofthe Zymbal's gland, the ear
canal, or the skin of the ear was observed among high
dose male rats. A significant increase in mammary ade-
nocarcinomas was observed among dosed female rats.
Theincidence ofhepatocellular carcinomas was signif-
icantly increased among female mice, but no significant
increase in liver tumors was observed amongmale mice.
Under the conditions of this bioassay, hydrazobenzene
was carcinogenicto Fischer344 ratsofboth sexes, causing
increasedincidences ofhepatocellularcarcinomaandZym-
bal's gland squamous-cell neoplasms inmale rats, neoplas-
tic nodules of the liver in female rats, and mammary
adenocarcinomas infemale rats. Hydrazobenzenewas also
carcinogenic tofemale B6C3F1 mice, causing anincreased
incidence ofhepatocellular carcinomas. The compoundwas
not carcinogenic to male B6C3F1 mice.
Synonym: 1,2-diphenylhydrazine
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Negative
Positive
TR-93 Bioassay of3-Amino-9-
ethylcarbazole Hydrochloride for Possible
Carcinogenicity (CASNo. 132-32-1)*
3-Amino-9-ethylcarbazole, is an aromatic amine dye
intermediate that has been used industrially in the man-
ufacture of C.I. Pigment Violet 23 and C.I. Direct Blue
108.
A bioassay of 3-amino-9-ethylcarbazole (hydro-
chloride) for possible carcinogenicity was conducted by
administering the test chemical in feed to Fischer 344
rats and B6C3F1 mice. Both the free amine and the
hydrochloride salt were used.
Groups of50 rats of each sex and 50 mice of each sex
were administered the test chemical at one oftwo doses,
either 800 or 2,000 ppm for rats and either 800 or 1,200
ppm formice, for 78weeks. The rats were then observed
for an additional 26-29 weeks, and the mice for an
additional16-17weeks. Controlsconsisted ofgroups of50
untreated rats of each sex and 50 untreated mice ofeach
sex; separate controls were used for the groups of ani-
mals administered the different doses. All survivingrats
were killed at 104-110 weeks; all surviving mice were
killed at 94-97 weeks.
Since the suppliers of the low-dose rats and mice
differed from those of the corresponding low-dose con-
trols,while the suppliers forthe high-dose rats andmice
were the same as those ofthe corresponding high-dose
controls, comparions ofthe high-dose groups with their
corresponding controls were the most appropiate. Fur-
thermore, since the low-dose animals did not receive the
same regimen ofadministration ofthe test compound as
that received by the high-dose animals, and since tests
using the low-dose groups were not performed concur-
rentlywiththoseusingthehigh-dose groups,analysesof
the dose-related trends were not possible. Although the
interpretation of results of the study was based pri-
marily on comparisons of high-dose groups with their
respective controls, the results obtained with the low-
dose groups, regardless of the indicated complicating
factors, supported the interpretation.
Neoplasms of the liver were observed in significant
incidences in rats and mice ofboth sexes. In male rats,
hepatocellular carcinomas alone were significantly
higher(P. 0.020) in both the low- and high-dose groups.
Whenneoplastic nodules oftheliverwere combinedwith
hepatocellular carcinomas, the combination occurred at
significant incidences (P.~ 0.012) in the low- and high-
dose male rats and in the high-dose female rats (males:
low-dosecontrols0/36,low-dose12/42;high-dosecontrols
1148, high-dose 22/48; females: high-dose controls 0/50,
high-dose 6/48). Hepatocellular carcinomas alone simi-
larly occurred at significant incidences (P<0.001) in the
low- and high-dose male and female mice (males: low-
dose controls 7/48, low-dose 32/44; high-dose controls
6/44, high-dose 41/49; females: low-dose controls 1/47,
low-dose36/43; high-dosecontrols1/45; high-dose43/49).
Papillomas or carcinomas of the integumentary sys-
temoccurred atsignificantincidences (P< 0.013) in both
the low- and high-dose male rats (low-dose controls 0/36,
low-dose 8/44; high-dose controls 0/48, high-dose 6/48);
these tumors also occurred in low- and high-dose female
rats, but not atincidences high enough to be statistically
significant (low-dose control 0/39, low-dose 4/44; high-
dose controls 0/50, high-dose 4/49).
CarcinomasoftheZymbal'sglandsoftheearoccurred
atsignificantincidences(P. 0.045) in the low- and high-
dosemale andfemalerats (males: low-dose controls0/36,
low-dose 5/44; high-dose controls 0/48, high-dose 7/48;
females: low-dose controls 0/39, low-dose 10/44; high-
dose controls 0/50, high-dose 12/49). These tumors were
first observed as early as week 47 on study.
Adenocarcinomas of the uterus or endometrium
occurred at a significantincidence (P=0.002) onlyin the
high-dosefemalerats(high-dose controls1150,high-dose
11/49); these tumors also occurred in the low-dose
females, but not at an incidence high enough to be
statistically significant (low-dose controls 4/38, low dose
11/43).
It is concluded that under the conditions of this bio-
assay,3-amino-9-ethylcarbazole (hydrochloride)was car-
cinogenic for the liver, inducing hepatocellular
carcinomas in Fischer344 rats and B6C3F1 mice ofboth
sexes. Other tumorsinduced inthe ratswere carcinomas
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or papillomas of the integumentary system in males,
carcinomas ofthe Zymbal'sglandofthe earinmalesand
females, and adenocarcinomas ofthe uterus.
Report Date: 1978
Levels of Evidence ofCarcinoge
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Positive
Positive
*The technical report states that 3-Amino-9-
ethylcarbazole Hydrochloride (CAS No. 6109-97-3) was
the actual chemical tested rather than 3-Amino-9-
ethylcarbazole inits pureform; therefore, the CAS num-
ber for 3-Amino-9-ethylcarbazole Hydrochloride is used
totrackthis studyinthe NTPCHEMTRACKdatabase.
TR-94 Bioassay of4-Amino-2-nitrophenol
for Possible Carcinogenicity (CAS No.
119-34-6)
4-Amino-2-nitrophenol is used as an industrial dye
intermediate, and as a constituent of"semi-permanent"
hair dyes.
A bioassay of 4-amino-2-nitrophenol for possible car-
cinogenicity was conducted by administering the test
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered 4-amino-2-nitrophenol at one oftwo doses,
either 1,250 or 2,500 ppm, for 103 weeks. Matched con-
trols consisted of groups of 20 untreated rats and 20
untreated mice of each sex. All dosed and matched-
control groups ofeach species and sexwere killed at 105
weeks.
Mean bodyweights ofdosed rats ofeach sexwere not
appreciably affectedbyadministration ofthe 4-amino-2-
nitrophenol, and mean body weights of dosed mice of
each sex were only slightly lower than those of corres-
ponding matched controls. Survival of neither rats nor
mice was affected by the test chemical, and sufficient
numbers ofanimals in dosed and control groups were at
riskforthe development oflate-appearingtumors. Since
both male and female mice receiving 4-amino-2-
nitrophenol had little or no depression in mean weights
and their survival was comparable to that of controls,
they may have been able to tolerate a higher dose.
In rats, transitional-cell carcinomas of the urinary
bladder showed a dose-related trend in the males
(P<0.001) and occurred at a significantly higher inci-
dence (P=0.018) in the high-dose males than in the
matched-control males (controls 0/15, low-dose 0/46,
high-dose 11139 [28%]). Carcinomas of the bladder also
occurred in one low-dose female and two high-dose
females, but in none ofthe control females. Transitional-
cellpapillomas ofthe bladder occurred in two additional
high-dose males, and transitional-cell hyperplasia ofthe
bladder occurred in four additional high-dose males, but
neitherlesionoccurredincontrolmales.Notumorsofthe
bladder were found among 220 male and 220 female
historical-control rats at this laboratory.
In mice, no tumors occurred in dosed groups ofmales
or females at incidences that were significantly higher
thanthoseinthecorrespondingmatched-control groups.
Deposition ofpigment occurred in the lamina propria
ofthe smallintestinein atleast91% ofthe animalsinthe
dosed groupsofrats andin atleast89% oftheanimals in
the dosed groups of mice, but in none of the control
groups ofeither species.
It is concluded that under the conditions of the bio-
assay, 4-amino-2-nitrophenol was carcinogenic for male
Fischer344rats,inducingtransitional-cellcarcinomasof
the urinary bladder; the transitional-cell carcinomas of
the urinarybladder observed in three dosed female rats
mayalsohavebeen associatedwith administration ofthe
4-amino-2-nitrophenol. The test chemical was not car-
cinogenic for male or female B6C3F1 mice at the doses
tested.
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats: Positive
Female Rats: Equivocal
Male Mice: Negative
Female Mice: Negative
TR-95 Bioassay of 3-(Chloromethyl)
pyridine Hydrochloride for Possible
Carcinogenicity (CAS No. 6959-48-4)
3-(Chloromethyl)pyridine hydrochloride is an inter-
mediate that has been proposed for use in the synthesis
of agricultural, pharmaceutical, and veterinary chemi-
cals.
A bioassay of3-(chloromethyl)pyridine hydrochloride
for possible carcinogenicity was conducted by admin-
istering the test chemical by gavage to Fischer 344 rats
and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered 3-(chloromethyl)pyridine hydrochloride in
avehicle ofdistilledwaterthreetimes perweek at one of
the following doses, either 75 or 150 mg/kg bodyweight
for the rats and either 100 or 200 mg/kgbodyweightfor
themice.Thelow-dose ratsweredosedfor103weeksand
the low-dose mice for102weeks. Because ofearlydeaths
in the high-dose animals, the high-dose rats were dosed
for only 83 weeks and the high-dose mice for only 81
weeks. Controls consisted of groups of 20 rats and 20
mice of each sex which were administered the vehicle
only for 104 weeks. All surviving rats and mice were
killed at 104 weeks.
Mean body weights ofthe male and female rats were
lower in the dosed groups than in the corresponding
control groups, and the depressions inweightwere dose
related. At the termination of the administration ofthe
test chemical to the high-dose groups ofrats, the mean
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body weights of these groups recovered rapidly. The
mean bodyweights ofthe male mice were unaffected by
the administration ofthe chemical; those ofthe females
were only slightly affected. Mortality was generally
higher in the dosed groups ofrats and mice than in the
corresponding control groups and was dose related in all
testsexceptthoseusingthefemalemice;however,suffici-
ent numbers of animals ofeach species and sex were at
risk for the development oflate-appearing tumors.
In rats, proliferative squamous-cell lesions ofthe for-
estomachwereobservedinthedosedmales (carcinomas:
high-dose1/50;papillomas: low-dose1/47;high-dose2/50;
hyperplasias: low-dose 1/47, high-dose 2/50) and the
dosedfemales(carcinomas: high-dose1/48),butnotinthe
maleorfemalevehiclecontrols.TheresultsoftheFischer
exact test were not significant for squamous-cell
papillomas or carcinomas. However, comparison of the
incidence of these tumors in the high-dose males with
that in 99 historical vehicle controls shows that the
probabilitythatthree ormore such tumors did not occur
by chance, given that none have been observed in the
controls in this laboratory, is P=0.014.
In mice, squamous-cell papillomas or carcinomas of
the forestomach occurred in the low- and high-dose
groups ofeach sex, but not in the corresponding control
groups. Theincidence inthehigh-dose maleswas signifi-
cantly higher (P=0.025) than that in the control males
(males: vehicle controls 0/19; low-dose 2/43; high dose
10/47 [21%]; females: vehicle controls 0/19, low-dose 1/45,
high-dose 5/48 [10%]). Comparison of the incidences of
these tumors in the high-dose males and females with
those observed in the corresponding control groups of
100 historical vehicle controls ofeach sex shows that the
probabilitythattheiroccurrencewasnotduetochanceis
P<0.001. Also, a life-table analysis of the incidence in
males indicated a significant (P=0.003) increase in
tumors over the period of observation (58 weeks to 104
weeks) in relation to an increase in dose.
Although the incidence of squamous-cell papillomas
and carcinomas in male and female rats was significant
only in males compared with historical vehicle controls,
these tumors are ofthe same type as those appearing at
the same site in male and female mice. Because these
tumors are rare and not found in controls, and because
they were found in dosed animals of both species, they
are considered to be related to administration ofthe test
chemical by gavage.
It is concluded that under the conditions of this bio-
assay, 3-(chloromethyl)pyridine hydrochloride was car-
cinogenic in male Fischer 344 rats and B6C3F1 mice of
both sexes, producing papillomas and carcinomas at the
site oftopical application, the stomach.
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Equivocal
Male Mice: Positive
Female Mice: Positive
TR-96 Bioassay of Coumaphos for
Possible Carcinogenicity (CAS No. 56-72-4)
Coumaphosis anorganophosphoruspesticidethatwas
developed in Germany by G. Schrader. Coumaphos,
which has arelativelylowmammalian toxicityin relation
to the other organophosphates, is used principally on
livestock and poultry to control ectoparasites.
A bioassay of coumaphos for possible carcinogenicity
wasconductedbyadministeringthetestchemicalinfeed
to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered the coumaphos in the diet at one of
two doses, either 10 or 20 ppm, for 103 weeks and then
observed for0-1 additionalweeks. Matched controls con-
sisted ofgroups of25 untreated animals ofeach species
and sex. All surviving animals were killed at 103-105
weeks.
Mean body weights of the dosed female rats were
lower than those ofcorresponding controls, while mean
body weights of dosed male rats and of dosed male and
femalemicewereessentiallyunaffected. Noclinicalsigns
that are typical of organophosphorus poisoning were
reported in either rats or mice. Survival ofthe rats and
mice was not affected by administration of the test
chemical. Thetestanimalsmayhavebeenabletotolerate
higherdoses. Sufficient numbers ofanimals in all groups
ofthe rats and mice were at risk for the development of
late-appearing tumors.
Inbothratsandmice, notumors occurredinthe dosed
groups ofeither sex atincidences thatwere significantly
higher than those in corresponding control groups.
It is concluded that under the conditions of this bio-
assay, coumaphos was not carcinogenic for either F344
rats or B6C3F1 mice.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-97 Bioassay ofTitanium Dioxide for
Possible Carcinogenicity (CAS No.
13463-67-7)
Titanium dioxide is awhite pigment possessing great
covering or opacifying power. It exists in three
crystalline forms: anatase, brookite, and rutile, but only
the anatase variety is used as a food color additive.
A bioassay of titanium dioxide for possible car-
cinogenicity was conducted by administering the test
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered titanium dioxide in the diet at one of
twodoses,either25,000 or50,000ppm,for103weeksand
then observed for 1 additional week. Matched controls
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consisted of 50 untreated rats of each sex and 50 un-
treatedmiceofeachsex.Allsurvivingratsandmicewere
killed at 104 weeks.
Administration of the titanium dioxide had no appre-
ciable effect on the mean bodyweights ofrats or mice of
eithersex.Withtheexceptionofwhitefeces,therewasno
other clinical sign that was judged to be related to the
administration of titanium dioxide. Survival of the rats
and the male mice at the end of the bioassay was not
affected by the test chemical; mortality in female mice
wasdoserelated. Sufficientnumbersofdosedandcontrol
rats and mice ofeach sexwere atriskfordevelopment of
late-appearing tumors.
In the female rats, C-cell adenomas or carcinomas of
the thyroids occurred at incidences that were dose
related (P=0.013), but were not high enough (P=0.043
for direct comparison of the high-dose group with the
control group) to meet the level ofP=0.025 required by
the Bonferroni criterion (controls 1148, low-dose 0/47,
high-dose 6/44). Thus, these tumors ofthe thyroid were
not considered to be related to the administration ofthe
test chemical.
In male and female mice, no tumors occurred in dosed
groups at incidences that were significantly higher than
those for corresponding control groups.
It is concluded that under the conditions of this bio-
assay, titanium dioxide was not carcinogenic by the oral
route for Fischer 344 rats or B6C3F1 mice.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-98 Bioassay ofdl-Menthol for
Possible Carcinogenicity (CAS No.
89-78-1)*
Menthol is a naturally occurring monocyclic terpene
found in the oils of the mint tree Mentha arvensis.
Menthol iswell known forits cooling effects and itsmint
flavor and odor, which arethebasis ofthemajority ofits
uses. The single largest use for menthol is probably in
cigarettes. A survey of pharmaceutical products indi-
catesthatmentholisformulatedinover-the-counterrubs
and liniments (2-10% concentrations), antipruritic
lotions, nasal sprays, expectorants, mouthwashes and
sprays, cough drops, and foot powders.
A bioassay of dl-menthol for possible carcinogenicity
wasconductedbyadministeringthetestchemicalinfeed
to Fischer 344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered dl-menthol at one of the following
doses, either 3,750 or 7,500 ppm for the rats and either
2,000 or 4,000 ppm for the mice, for 103 weeks, then
observed for 1 or 2 additional weeks. Matched controls
consisted of50 untreated rats ofeach sex and 50 untre-
atedmiceofeachsex.Allsurvivingratswerekilledat105
weeks and all surviving mice at 104 weeks.
Mean bodyweights ofdosed rats and mice were only
slightly lower than those ofcorresponding controls. No
other clinical signs related to administration of the dl-
menthol were noted in the dosed groups of animals. A
dose-related trend inmortalitywas observed onlyinthe
female mice. Survival at the end of the bioassay was at
least 62% in all dosed and control groups of animals of
each species, and sufficient numbers ofanimals were at
risk for the development oflate-appearing tumors.
In male rats, no tumors occurred at incidences which
were consideredtoberelated totheadministration ofdl-
menthol.
In female rats, no tumors occurred at higher inci-
dences in the dosed groups than in the control groups.
Fibroadenomas ofthemammaryglandoccurredatlower
incidences in the low-dose (10/49) and high-dose (7/49)
groups than in the control group (20/50), and alveolar/
bronchiolar adenomas or carcinomas of the lung
occurred only in the controls (3/50).
In mice of either sex, no tumors occurred in dosed
groups at incidences that were significantly different
from those for corresponding control groups.
It is concluded that under the conditions of this bio-
assay, dl-mentholwasnotcarcinogenicforeitherFischer
344 rats or B6C3F1 mice.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
*The ChemicalAbstracts Service (CAS) Registry Num-
ber used to track this bioassay in the NTP
CHEMTRACK database is 15356-70-4 which is deter-
mined to best define the material used in the conduct of
this bioassay.
TR-99 Bioassay ofPhenazopyridine
Hydrochloride for Possible Carcinogenicity
(CASNo.136-40-3)
Phenazopyridinehydrochlorideisthegenericnamefor
an azo dye which has been used for 40 years as an
analgesic drug to reduce pain associated with urinary
tract infections. It is marketed both alone and in
combination with the sulfonamide urinary tract
antiseptics.
A bioassay of phenazopyridine hydrochloride for
possiblecarcinogenicitywasconductedbyadministering
the testchemicalinfeed to Fischer344 rats andB6C3F,
mice.
Groups of 35 rats and 35 mice of each sex were
administered phenazopyridine hydrochloride at one of
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thefollowingdoses, either3,700or7,500ppmforratsand
either 600 or 1,200 ppm for mice. The rats were admin-
isteredthechemicalfor78weeks,thenobservedfor26or
27 additional weeks; the mice were administered the
chemicalfor80weeks,thenobservedfor25-27additional
weeks. Matched controls consisted of 15 untreated rats
and15untreatedmiceofeachsex.Allsurvivingratswere
killed at 104 or 105 weeks, all surviving mice at 105-107
weeks.
Mean bodyweights ofthe dosed rats and mice ofeach
sexwere consistently lower than those ofcorresponding
control animals, and the depressions in mean body
weightweredose related. Mortalityinthe groups ofrats
andmice didnot, however, showdose-relatedtrends, and
sufficient numbers ofanimals ofboth dosed and control
groupswereatriskforthedevelopmentoflate-appearing
tumors.
In male rats, adenomas or adenocarcinomas of the
large intestine (colon or rectum) occurred at incidences
having a significant dose-related trend (P=0.015). The
direct comparison ofthe incidences in each ofthe dosed
groupswith that in the control groupwas notsignificant
(controls 0/14, low-dose 4/34, high-dose 8/35). In the
females,3/33low-doseand5/32high-doseanimals, butno
control animals, had this tumor. In addition, sarcomas
were observed in the colon ofone low-dose male and one
high-dose female. The laboratory historical records
showed noincidence ofadenomas oradenocarcinomas of
the large intestine in 260 females and only one ade-
nomatous polyp in 260 males. Assuming a spontaneous
incidence of11261 (0.038%) and abinomial distribution of
such tumors, the occurrence seen in themale and female
high-dose groups areboth significantly (P<0.001) differ-
ent from the expected value. Thus, these tumors are
considered to be related to administration of the test
chemical.
Infemale mice, the combinedincidence ofhepatocellu-
laradenomas and carcinomas showed asignificant dose-
related trend (P=0.002), and the incidence in the high-
dose group was significant (P=0.003) when compared
with that in the control group (controls 2/15, low-dose
11134, high-dose 19/32). The incidence of hepatocellular
carcinomas, considered alone, also was significant in
femalemice,showingadose-related trend(P=0.010)and
a P value of 0.039 for the comparison of the high-dose
groupwith the control group. Inthemales, the combined
incidence of hepatocellular adenomas and carcinomas
was not significant.
It is concluded that under the conditions of this bio-
assay, phenazopyridine hydrochloride was carcinogenic
in Fischer 344 rats, inducing adenocarcinomas of the
colon in both males and females. Although phe-
nazopyridine hydrochloride was notcarcinogenic inmale
B6C3F1 mice, the chemical was carcinogenic in females,
inducing hepatocellular adenomas and carcinomas.
Synonym: 2,6-diamino-3-(phenylazo)-pyridine mono-
hydrochloride
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Positive
TR-100 Bioassay ofCupferron for
Possible Carcinogenicity (CAS No.
135-20-6)
Cupferron, an N-nitroso hydroxylamine derivative
used primarily as a reagent in analytical chemistry, was
selected for bioassay by the National Cancer Institute
because of the suspected carcinogenicity of nitro-
samines.
A bioassay of cupferron for possible carcinogenicity
was conducted using Fischer344 ratsand B6C3F1 mice.
Cupferron was administered in the feed, at either oftwo
concentrations, to groups of49 or 50 male and 50 female
animals ofeach species. Thetime-weighted average high
and low dietary concentrations of cupferron were,
respectively, 0.30 and 0.15 percent for male and female
rats, and 0.4 and 0.2 percent for male and female mice.
After a 78-week period of compound administration,
observation oftheratscontinuedforanadditionalperiod
ofup to 28 weeks and observation ofthe mice continued
for an additional period ofup to 18weeks.
Foreachspecies, 50animals ofeach sexwereplaced on
test as controls and fed only the basal diet.
Amongboth sexes ofrats andmicetherewas asignifi-
cant positive association between the dose of cupferron
administered and mortality; however, in all groups of
animals sufficient numbers survived long enough to
establish the carcinogenicity ofthis compound.
There were significant positive associations between
the concentrations of cupferron administered to male
and female rats and the incidences of: squamous-cell
carcinomas of the forestomach, hepatocellular car-
cinomas and neoplastic nodules, and hemangiosarcomas.
When a binomial distribution and a spontaneous inci-
dence rate corresponding to the appropriate historical
control incidence were assumed, the incidences of audi-
tory sebaceous gland neoplasms in female rats and
female mice were significant. There were significant
positive associations between the concentrations admin-
istered and the incidences of hepatocellular carcinomas
in female mice, the incidences of hemangiosarcomas in
both sexes ofmice, and theincidence ofHarderian gland
adenomas in both sexes ofmice.
Under the conditions of this bioassay cupferron was
carcinogenic in Fischer 344 rats, causing hemangiosar-
comas, hepatocellular carcinomas, and squamous-cell
carcinomas ofthe forestomach in males and females as
well as carcinomas of the auditory sebaceous gland in
females. The chemical was also carcinogenic in B6C3F1
mice, causing hemangiosarcomas in males and
hepatocellular carcinomas, carcinomas of the auditory
sebaceous gland, a combination of hemangiosarcomas
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andhemangiomas, and adenomas ofthe Harderiangland
in females.
Synonyms: N-hydroxy-N-nitroso-benzeneamine, am-
monium salt; N-nitroso-N-phenyl-hydroxylamine,
ammonium salt; ammonium nitrosophenylhydrox-
ylamine
Report Date: 1978
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Positive
Positive
TR-101 Bioassay of Formulated
Fenaminosulffor Possible Carcinogenicity
(CAS No. 140-56-7)
Fenaminosulf, an aromatic diazo compound used
exclusively as afungicide, was selected forbioassayby the
National Cancer Institute because of conflicting reports
concerning its ability to induce hepatomas in rats.
A bioassay of formulated fenaminosulf for possible
carcinogenicity was conducted using Fischer 344 rats
andB6C3F1 mice. Fenaminosulfwas administeredinthe
feed, ateitheroftwo concentrations, to groups of50male
and 50 female animals of each species. The time-
weighted average high and lowdietaryconcentrations of
fenaminosulfwere, respectively, 0.10 and 0.05 percent for
rats,0.19and0.10percentformalemice,and0.10and0.05
percent for female mice. After a 78-week period of com-
pound administration, observation ofthe rats continued
for up to an additional 31 weeks and observation of the
mice continued for up to an additional 19 weeks.
Fiftymale mice and 50rats ofeach sex were placed on
test as controls and fed only the basal diet. For female
mice, 50 animals served as controls for the high dose
group and 50 as controls for the low dose group.
For female rats there was no significant association
between fenaminosulfdosage andmortalityand, ifthe21
male rats that died in the first twoweeks ofthe bioassay
were excluded from consideration, the same was true for
male rats. For both male and female mice there was a
significantpositive association between dosage and mor-
tality. In all groups of both species, however, adequate
numbers of animals survived sufficiently long to be at
risk from late-developing tumors.
No convincing, statistically significant positive asso-
ciations were demonstrated between administration and
theincidence ofneoplasms in either sex ofeither species.
An increased incidence ofnecrosis and mineralization of
the tubular cells ofthe renal papilla occurred in treated
rats and mice. These nonneoplastic lesions were not
present in control animals ofeither species.
Under the conditions of this bioassay, dietary admin-
istration of formulated fenaminosulf was not car-
cinogenic in either Fischer 344 rats or B6C3F1 mice.
Synonyms: sodium4-(dimethylamino)phenol diazenesul-
fonate; p-dimethylaminobenzenediazo sodium sulfonate;
sodium 4-dimethylaminobenzenediazosulfonate; DAS;
Dexong; Diazoben; Bayer22555
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-102 Bioassay of3-Sulfolene for
Possible Carcinogenicity (CAS No. 77-79-2)
3-Sulfolene is an intermediate in the production of
sulfolane, which is used in the petroleum, plastics, and
textile industries, and in the synthesis of one of more
fungicides or additional chemicals. 3-Sulfolene is also
used as a catalyst.
A bioassay of3-sulfolene for possible carcinogenicity
was conducted using Osborne-Mendel rats and B6C3F1
mice. 3-Sulfolene incornoilwasadministeredbygavage,
at either of two dosages, to groups of 50 male and 50
female animals of each species. The 78-week period of
chemical administration was followed by an observation
period of33 weeks forthe high dose female rats and low
dose rats ofboth sexes. The last high dose male rat died
inweek 60. All treated groups ofmicewere observed for
an additional 13 weeks following chemical administra-
tion.
Initial dosage levels for the chronic bioassay were
selected on the basis ofapreliminary subchronic toxicity
test. Subsequent dosage adjustments were made during
the course of the chronic bioassay. The time-weighted
average high and low doses of3-sulfolene in the chronic
studywere respectively, 372 and 197mg/kg/dayformale
rats, 240 and 120 mg/kg/day for female rats, 622 and 311
mg/kg/dayformale mice and 768 and 384 mg/kg/dayfor
the female mice.
Foreachspecies,20animalsofeachsexwereplaced on
test as vehicle controls. These animals were gavaged
with corn oil at the same time that dosed animals were
gavaged with the 3-sulfolene mixtures. Twenty animals
ofeach sexwere placed on test as untreated controls for
each species. These animals were not intubated.
There was a signiflcant positive association between
the administered dosages of3-sulfolene andmortalityin
both sexesofratsandmice. In allgroups, exceptthehigh
dose male rats and the high dose male and female mice,
adequate numbers of animals survived sufficiently long
to be at risk from late-developing tumors.
There were no tumors in either sex ofrats or mice for
which a significant positive association could be estab-
lished between chemical administration and incidence.
Under the conditions of this bioassay, there was no
evidence for the carcinogenicity of 3-sulfolene to
Osborne-Mendel rats or B6C3F1 mice.
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Synonyms: 2,5-dihydrothiophene 1,1-dioxide; 1-thia-3-
cyclopentene 1,1-dioxide; butadiene sulfone
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
incidence of sarcomas, fibrosarcomas, and especially
rhabdomyosarcomas oftheintegumentary system in the
male B6C3F1 mice suggested thatthe test chemical was
carcinogenic in these animals.
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Equivocal
Negative
TR-103 Bioassay of Fenthion for Possible
Carcinogenicity (CAS No. 55-38-9)
Fenthion, the 0,0-dimethyl esterof0-(4-(methylthio)-
m-tolylphosphorothioic acid, is one of the organophosp-
hate pesticides. It was developed by G. Schrader and E.
Schegk and first marketed by Farbenfabriken Bayer
A.G. as an insecticide in 1957.
Abioassayoffenthionforpossible carcinogenicitywas
conducted by administering the test chemical in feed to
F344 rats and B6C3F1 mice.
Groups of 50 rats ofeach sex and 50 mice of each sex
were administered fenthion in the diet at one of two
doses, either 10 or 20 ppm, for 103 weeks and then
observed for 0 to 2 additional weeks. Matched controls
consisted of groups of 25 untreated animals of each
species and sex. All surviving animals were killed at 103
to 105 weeks.
The mean body weights and the survival ofthe dosed
animals were essentiallyunaffected byadministration of
the testchemical with the exception ofthe survival ofthe
low-dose male mice, which was significantly lower than
thatofthe correspondingmatched control. Thus, mostof
the animals may have been able to tolerate higher doses.
Sufficient numbers of animals in all groups of rats and
mice were at risk for development of late-appearing
tumors.
In the male and female rats and the female mice, no
tumors occurred at incidences that were significantly
higher in dosed groups than in control groups.
In the male mice, sarcomas, fibrosarcomas, or rhab-
domyosarcomas of the integumentary system occurred
atincidences thatwere dose related (P =0.043). In direct
comparisons of the incidences of these tumors in the
dosed groupswith the incidence in the control group, the
P values of 0.048 and 0.028 for the low- and high-dose
groups, respectively, did not meet the Bonferroni crite-
rion of P =0.025 for significance when multiple com-
parisons are made (controls 0/25, low-dose 7/49 or 14%,
high-dose 8/48 or 17%). However, the incidence of sar-
comas and fibrosarcomas in historical-control male
B6C3F1 miceusedinbioassays ofotherchemicals tested
at this laboratory was 7/435 (1.6%), and no rhab-
domyosarcomas occurred in the historical-control male
mice.
It is concluded that under the conditions of this bio-
assay, fenthion was not carcinogenic for male or female
F344 rats or for female B6C3F1 mice. The increased
TR-104 Bioassay ofAnilazine for Possible
Carcinogenicity (CAS No.101-05-3)
Anilazine is a triazine fungicide originally synthesized
and screenedforherbicidal activity.Although anilazineis
virtually nonphytotoxic, it was found to have broad-
spectrum fungicidal effects, andwas marketed in 1955 as
an agricultural fungicide.
A bioassay of anilazine for possible carcinogenicity
was conductedbyadministeringthetestchemicalinfeed
to Fischer 344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered anilazine at one oftwo doses, either 500 or
1,000 ppm, for 103 weeks and then observed for 1-6
additionalweeks. Matchedcontrols consistedof25untre-
ated rats and25untreatedmice ofeach sex.All surviving
ratswere killed at103-104weeks; all survivingmicewere
killed at 107-109 weeks.
Administration of the anilazine had no appreciable
effect on body weight in the rats and female mice;
however, there was a decreased gain in mean body
weight in the dosed male mice. Survival also was essen-
tially unaffected. Survival in all groups of dosed and
control rats and mice was at least 80% at the end of 90
weeks on study, except for the male control mice; thus,
sufficientnumbers ofanimalswere atriskin mostgroups
for development oflate-appearing tumors.
No tumors occurred in dosed rats or mice ofeither sex
atincidences thatwere significantlyhigher than those in
correspondingcontrols. Male and female rats and female
mice may have been able to tolerate higher doses.
It is concluded that under the conditions of this bio-
assay, anilazine was not carcinogenic for either Fischer
344 rats or B6C3F1 mice.
Synonym: 2,4-dichloro-6-(o-chloroanilino)-s-triazine
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
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TR-105 Bioassay of m-Cresidine for
Possible Carcinogenicity (CAS No.
102-50-1)
m-Cresidine, an aromatic amine and dyestuff inter-
mediate, was selected for bioassay by the National Can-
cer Institute because of the high incidence of bladder
cancer associated with exposure to aromatic amines and
several other classes ofchemicals amongworkers in the
dye manufacturing industry.
Abioassayoftechnical-grade m-cresidine forpossible
carcinogenicity was conducted using Fischer 344 rats
and B6C3F1 mice. m-Cresidine in corn oil was admin-
istered by gavage five days a weeks at either of two
dosages,togroupsof50maleand49or50femaleanimals
ofeach species.Thedosagesusedinthechronicbioassay
forlowand high dose ratswere 0.08 and 0.16 gn/kg/day,
respectively. The time-weighted average dosages used
forlowandhigh dosemicewere 0.06and 0.11gnmkg/day,
respectively. After a 77-week dosing period observation
ofratscontinued foranadditional32to33weeks.Aftera
53-week dosingperiod, observation ofmicecontinued for
an additional observation period ofup to 41 weeks. For
each species, 50 animals ofeach sex were placed on test
as untreated controls and 25 animals of each sex were
placed on test as vehicle controls.
The urinary bladder and the kidney were the target
organs of m-cresidine toxicity in male and female rats.
Papillary transitional-cell carcinomas of the urinary
bladderoccurredin0/45lowdosemales,5/44(11percent)
high dose males, 1/46 (2 percent) low dose females, and
2/44 (5 percent) high dose females but did not occur in
any untreated control or vehicle control rats. Although
the incidences in each dosed rat group were not statis-
tically significant when compared to vehicle controls,
comparison with historical controls indicates that these
bladder carcinomas are rare and are, therefore, consid-
ered to be compound-related in both sexes.
Among mice, dose-related nonneoplastic lesions were
observed at higher incidences for males than females in
the kidneys, spleen and thymus. Dose-related toxic
effects were also observed in testes of male mice. No
neoplasms occurred in male mice at statistically signifi-
cant incidences.
Underthe conditions ofthis bioassay, m-cresidinewas
carcinogenic to Fischer 344 rats, causing papillary
transitional-cell carcinomas of the urinary bladder in
both sexes. No convincing evidence was provided for
carcinogenicity in female B6C3F1 mice. Poor survival of
maleB6C3F1 micereceivingm-cresidineprecluded eval-
uation ofthepossible carcinogenicity ofthecompound in
these animals.
Synonyms: 4-methoxy-2-methylbenzenamine; 4-me-
thoxy-2-methylaniline; 2-methyl-p-anisidine
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Inadequate Study
Negative
TR-106 Bioassay ofTrichlorofluoro-
methane for Possible Carcinogenicity
(CASNo. 75-69-4)
Trichlorofluoromethane, a widely used halocarbon
aerosol propellant and refrigerant, was selected for bio-
assaybythe National Cancer Institute because ofwide-
spread exposure to this compound resulting from the
indiscriminate use of aerosol sprays, and the well-
documented hepatocarcinogenicity of the structurally
analogous compound, carbon tetrachloride.
The bioassay of technical-grade trichloro-
fluoromethane for possible carcinogenicity was con-
ducted using Osborne-Mendel rats and B6C3F1 mice.
Trichlorofluoromethane in corn oil was administered by
gavage, ateitheroftwodosages,togroupsof50maleand
50femaleanimalsofeachspecies, 5daysperweek, overa
period of78weeks. The time-weighted average high and
low dosages of trichlorofluoromethane in the chronic
bioassay were, respectively, 977 and 488 mg/kg/day for
male rats, 1,077 and 538 mg/kg/day for female rats, and
3,925 and1,962 mg/kg/dayformice ofboth sexes. After a
78-week dosing period, rats were observed for an addi-
tional period ofup to 33 weeks and mice were observed
for an additional period ofup to 13 weeks.
Foreachspecies,20animalsofeachsexwereplaced on
test as vehicle controls. These animals were gavaged
with corn oil at the same time that dosed animals were
gavagedwithtrichlorofluoromethane. Twentyanimals of
each sex were placed on test as untreated controls for
each species. These animals were not gavaged.
A high rate ofearly deaths occurred among male and
female rats in this bioassay. An insufficient number of
rats ofeither sexsurvivedlongenough tobe atriskfrom
late- developing tumors. Survival of mice was adequate
for meaningful statistical analysis of late-developing
tumors.
Resultsofatime-adjusted statisticalanalysisoftumor
incidenceinratsindicatednosignificantpositiveassocia-
tions between administration oftrichlorofluoromethane
and tumor incidence.
No groups ofmale or female mice dosed with trichlo-
rofluoromethane had significantly increased tumor inci-
dences relative to their respective control groups.
The results ofthe bioassay oftrichlorofluoromethane
in Osborne-Mendel rats for possible carcinogenicity are
not conclusive because inadequate numbers of rats sur-
vived sufficiently long enough to be at risk from late-
developingtumors. Underthe conditions ofthisbioassay,
trichlorofluoromethane was not carcinogenic to male or
female B6C3F1 mice.
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Synonyms: trichloromonofluoromethane; fluorotri-
chloromethane; Fluorocarbon 11; Propellant 11; Freon
11i; Arcton 11i; Frigen 90
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Inadequate Study
Female Rats: Inadequate Study
Male Mice: Negative
Female Mice: Negative
TR-107 Bioassay of5-Nitro-o-toluidine
for Possible Carcinogenicity (CAS No.
99-55-8)
5-Nitro-o-toluidine, anintermediateinthesynthesisof
azo dyes, was selected for bioassay by the National
Cancer Institute in an attempt to elucidate those chemi-
calswhichmayberesponsiblefortheincreasedincidence
of bladder cancer observed among workers in the dye
manufacturing industry.
A bioassay of 5-nitro-o-toluidine for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 5-Nitro-o-toluidine was administered in the
feed, at either oftwo concentrations, to groups of50 male
and 50 female animals ofeach species. The time-weighted
average high and low dietary concentrations of 5-nitro-
o-toluidine were, respectively, 0.01 and 0.005 percent for
rats, and 0.23 and 0.12 percent for mice. After a 78-week
period ofcompoundadministration, observationoftherats
continuedfor an additional 30 to 31weeks and observation
ofthe mice continued for up to an additional 20 weeks.
Foreach species, 50animalsofeach sexwereplaced on
test as controls and fed only the basal diet.
There were no significant positive associations between
the concentration of 5-nitro-o-toluidine administered and
mortality in rats or mice of either sex, and adequate
numbers ofanimals in all groups survived sufficiently long
to be at risk from late-developing tumors.
Nounusual tumorswere observed in rats ofeither sex
and no convincing statistical evidence was provided for a
significant positive association between compound
administration andtheincidence ofanyneoplasminrats.
Among mice there was a statistically significant posi-
tive association between administration ofthe chemical
and the incidences ofhepatocellular carcinomas in both
males and females. The combined incidence of
hemangiomas and hemangiosarcomas in male mice and
the incidence ofhemangiosarcomas in female mice were
not statistically significant in relation to theirrespective
control groups. However, they were considered to be
associated with compound administration since they
rarely occur in untreated B6C3F1 mice.
Under the conditions of this bioassay 5-nitro-
o-toluidine was carcinogenic in B6C3F1 mice, causing
hepatocellular carcinomas in both sexes, an increase in
the combined incidence ofhemangiomas and hemangio-
sarcomas in male mice, and an increased incidence of
hemangiosarcomas in female mice. The compound was
not carcinogenic in Fischer 344 rats.
Synonyms: 2-methyl-5-nitro-benzeneamine; 4-nitro-2-
aminotoluene; 6-methyl-3-nitroaniline; Fast Scarlet
Base G; Colour Index Azoic Diazo Component 12
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
TR-108 C.I. DirectBlack38
(CAS: 1937-37-7) C.I. Direct Blue 6
(CAS: 2602-46-2) C.I. Direct Brown 95
(CAS: 16071-86-6)
These studies were reported in the NCI Car-
cinogenesis Technical Report Series and assigned a
Technical Report number; however because they reflect
the results of13-week subchronic studies, abstracts are
notincluded inthis compendium. SeeAppendixA, Table
Al for ordering information.
TR-109 Bioassay of 4-Nitroanthranilic
Acid for Possible Carcinogenicity (CAS No.
619-17-0)
4-Nitroanthranilic acid, a nitrobenzene derivative for-
merly used as a dye intermediate, was selected for bio-
assay by the National Cancer Institute alongwith other
dye intermediates in an attempt to identify those chemi-
calswhichmayberesponsiblefortheincreasedincidence
of bladder cancer observed among workers in the dye
manufacturing industry.
A bioassay of4-nitroanthranilic acid for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 4-Nitroanthranilic acid was administered
in the feed, at either oftwo concentrations, to groups of
50 male and 50 female animals ofeach species. The high
and low time-weighted average concentrations used for
the chronic studywere, respectively, 1.5 and 0.46percent
forratsand1.0and0.46percentformice.Aftera78-week
period of chemical administration, the rats were
observed for an additional period ofup to 32 weeks and
the mice for an additional period ofup to 17 weeks. For
rats 50 animals of each sex were placed on test as low
dose controls and 25 animals ofeach sex were placed on
test as high dose controls. For mice 50 animals of each
sex were placed on test as controls for each dose group.
No statistically signiflcant increases in tumor inci-
dence were observed among rats or mice receiving diets
containing 4-nitroanthranilic acid.
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Undertheconditions ofthisbioassayevidencewas not
provided for the carcinogenicity of 4-nitroanthranilic
acid in Fischer 344 rats or B6C3F1 mice.
Synonym: 2-amino-4-nitro-benzoic acid
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-ll0 Bioassay of lodoform for Possible
Carcinogenicity (CAS No. 75-47-8)
Iodoform, a halogenated alkane with antiseptic and
anti-infectiveproperties,wasselectedforbioassaybythe
National Cancer Institute because of its similarity to
methyl iodide, which has produced sarcomas in BD rats
and to chloroform, a compound which has been found to
induce hepatomas in NLC mice.
A bioassay for possible carcinogenicity of technical-
grade iodoform was conducted using Osborne-Mendel
rats and B6C3F1 mice. Iodoform in corn oil was admin-
istered by gavage, at either oftwo dosages, to groups of
50 male and 50 female animals of each species. Admin-
istration ofthe chemical occurred 5 days perweek, for a
period of78 weeks, followed by an observation period of
34 weeks for rats and 13 or 14 weeks for mice. The high
and low time-weighted average dosages of iodoform
were,respectively, 142and 71mg/kg/dayformalerats, 55
and 27 mg/kg/day for female rats, and 93 and 47mg/kg/
day for male and female mice. For each species, 20
animals of each sex were placed on test as vehicle con-
trols. These animals were gavaged with pure corn oil at
the same rate as the high dose group of the same sex.
Twenty animals of each sex were placed on test as
untreated controls for each species. These animals were
not intubated.
A significant positive association between dosage and
mortality was observed in male rats but not in female
rats or in mice of either sex. Adequate numbers of
animals in all groups survived sufficiently long to be at
risk from late-developing tumors.
No statistical significance could be attributed to the
incidences ofany neoplasms in rats or mice ofeither sex
when compared to their respective controls.
Under the conditions of this bioassay, no convincing
evidence was provided for the carcinogenicity of
iodoform in Osborne-Mendel rats or B6C3F1 mice.
Synonym: triiodo-methane
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-llM Bioassay of1-Amino-2-
methylanthraquinone for Possible
Carcinogenicity (CAS No. 82-28-0)
1-Amino-2-methylanthraquinone, an intermediate in
the synthesis ofanthraquinone dyes and adyeitself,was
selected forbioassaybythe National Cancer Institute in
an attempt to elucidate those chemicals which may be
responsible fortheincreased incidence ofbladdercancer
observed among workers in the dye manufacturing
industry.
A bioassay for possible carcinogenicity of technical-
grade 1-amino-2-methylanthraquinone was conducted
using Fischer 344 rats and B6C3F1 mice. 1-Amino-2-
methylanthraquinone was administered in the feed, at
either oftwo concentrations, to groups of45 to 50 males
and females of each species. The high and low time-
weighted average concentrations of 1-amino-2-
methylanthraquinone were0.20and0.10percent, respec-
tively, for male and female rats. For mice, two dosage
regimens (designated A and B) were used, but the time-
weighted average concentrations were the same, 0.06
percent. For each species, 50 animals of each sex were
placed on test as controls. The period of compound
administrationwas 78weeksforratsfollowedby26to28
additional weeks of observation, and 73 weeks for mice
followed by 24 to 25 additional weeks ofobservation.
Astatistically significant positive association between
compound administration and mortalitywas established
forthemale andfemaledoseAmice. DoseAmicedid not
survive sufficiently long to be at risk from late-
developing tumors. Survival in all other groups was
adequate.
Theincidence ofhepatocellular carcinomas was statis-
ticallysignificantamongdosedratsofbothsexes. Kidney
neoplasms (the combined incidence of tubular-cell ade-
nomas, tubular-cell adenocarcinomas, and adenocar-
cinomas NOS)were significantlyincreased amongdosed
male rats.
Administration ofthecompoundwas associatedwith a
significant increase in the combined incidence of
hepatocellularcarcinomas andneoplasticlivernodulesin
femalemice. Nootherneoplasmsoccurredinstatistically
significant positive incidences in male or female mice.
1-Amino-2-methylanthraquinone demonstrated
nephrotoxic properties in mice ofboth sexes.
Under the conditions of this bioassay, 1-amino-2-
methylanthraquinone was carcinogenic in Fischer 344
rats, inducing hepatocellular carcinomas in rats of both
sexes,andkidneytumorsinmalerats.Thecompoundwas
carcinogenic in female B6C3F1 mice, producing an
increased combined incidence of hepatocellular car-
cinomas and neoplastic nodules.
Synonyms: 1-amino-2-methyl-9,10-anthracenedione;
2-methyl-1-anthraquinonylamine; Disperse Orange 11
Report Date: 1978
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Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Negative
Positive
TR-112 Bioassay of 3-Amino-4-
ethoxyacetanilide for Possible
Carcinogenicity (CAS No. 17026-81-2)
3-Amino-4-ethoxyacetanilide, an azo dye intermediate
closely related to the para-aminophenol analgesics, was
selected for bioassay by the National Cancer Institute
because of the increased incidence of bladder cancer
reported among workers in the dye manufacturing
industry.
Abioassayof3-amino-4-ethoxyacetanilide forpossible
carcinogenicity was conducted using Fischer 344 rats
and B6C3F1 mice. 3-Amino-4-ethoxyacetanilide was
administered in the feed, at either oftwo concentrations,
to groups of approximately 50 male and 50 female ani-
mals ofeach species. The dietary concentrations used in
the chronic bioassay for low and high dose rats were 0.4
and 1.5 percent, respectively. The dietary concentrations
usedforlowandhigh dosemice were 0.4 and 0.8percent,
respectively. After a 78-week period ofchemical admin-
istration,observationofratscontinuedforupto18weeks.
For each species, 50 animals ofeach sex were placed on
test ascontrolsforlowdose groupsandapproximately50
animals of each sex were placed on test as controls for
high dose groups.
In both species, adequate numbers of animals in all
groups survived sufficiently long enough to be at risk
from late-developing tumors.
Among rats the only clearly compound-related lesion
was hemosiderosis of the thyroid gland. No neoplastic
lesions were statistically significant in dosed rats.
Amongmice the incidence offollicular-cell carcinomas
ofthe thyroid gland was significant for high dose males.
An elevated incidence of thyroid hyperplasia was
observed in each dosed group. Hemosiderosis of the
thyroid cells were found in nearly all dosed mice, but not
in any control mice.
Under the conditions of this bioassay, 3-amino-4-
ethoxyacetanilide was carcinogenic in male B6C3F1
mice, causing follicular-cell carcinomas of the thyroid
gland. Evidence provided by this bioassay was insuffi-
cient to establish the carcinogenicity of 3-amino-4-
ethoxyacetanilide in female mice orin Fischer344 rats of
either sex.
Synonyms: 3-amino-4-ethoxy-N-phenylacetamide; N-(3-
amino-4-ethoxyphenyl) acetamide; 3-amino-p-aceto-
phenetidin
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-113 Bioassay of2-Chloro-
p-phenylenediamine Sulfate for Possible
Carcinogenicity(CASNo. 61702-44-1)
2-Chloro-p-phenylenediamine sulfate is a salt of
2-chloro-p-phenylenediamine and sulfuric acid. It is a
component ofcommercial hair dyes and was selected for
bioassaybythe National Cancer Institutebecause ofthe
increased bladder cancer incidence noted among dye
manufacturing workers.
A bioassay for possible carcinogenicity of 2-chloro-
p-phenylenediamine sulfatewasconductedusingFischer
344 rats and B6C3F1 mice. 2-Chloro-p-phenylene-
diamine sulfatewas administered inthefeed, ateitherof
two concentrations, to groups of 50 male and 50 female
animals ofeach species. The dietaryconcentrations used
in the chronic bioassaywere 0.3 and 0.15 percent for the
high and low dose rats, respectively, and 0.6 and 0.3
percent for the high and low dose mice, respectively.
Compound administration was for 105 to 107 weeks in
rats, 87weeks in high dose mice, and 104 to 105weeks in
low dose mice. The only groups observed during an
untreated period after dosing were the high dose mice,
observed for 18 weeks after compound administration
ceased. For each species, 20 animals of each sex were
placed on test as controls.
There were no significant positive associations
between the administered dietary concentrations of
2-chloro-p-phenylenediamine sulfate and mortality for
rats of either sex or male mice. There was a significant
positive association between dosage and mortality for
femalemice;however, adequatenumbersofanimalsinall
groups survived sufficiently long to be at risk from late-
developing tumors.
Therewerenostatisticallysignificantpositive associa-
tions between dietary exposure to the compound and the
incidences ofany tumor in rats. There was an increased
incidence of transitional-cell hyperplasia of the renal
pelvic epithelium in both male and female rats, and
transitional-cell tumors of the urinary bladder were
present in three dosed rats. These lesions indicated a
possible carcinogenic effect, but are not considered as
sufficientevidence ofcarcinogenicity. Inmice, no tumors
occurredinstatisticallysignificantlyhigherincidences in
the dosed mice than in controls.
Undertheconditionsofthisbioassaytherewasinsuffi-
cient evidence that dietary administration of 2-chloro-
p-phenylenediamine sulfate was carcinogenic to Fischer
344 rats and B6C3F1 mice.
Synonyms: 2-chloro-1,4-benzenediamine sulfate;
3-chloro-4-aminoaniline sulfate; o-chloro-p-phenylene-
diamine sulfate; C.I. Oxidation Base 13A; Ursol Brown 0
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Report Date: 1978
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-114 Bioassay of2,3,5,6-Tetrachloro-4-
nitroanisole for Possible Carcinogenicity
(CASNo.2438-88-2)
2,3,5,6-Tetrachloro-4-nitroanisole, an agricultural
fungicide and acaricide, was selected forbioassaybythe
National Cancer Institute because ofits structural sim-
ilarity to pentachloronitrobenzene, a pesticide classified
as tumorigenic by the Secretary's Commission on
Pesticides and their Relationship to Environmental
Health.
A bioassay for possible carcinogenicity of 2,4,5,6-
tetrachloro-4-nitroanisole was conducted using Fischer
344 rats and B6C3F1 mice. 2,3,5,6-Tetrachloro-4-
nitroanisolewasadministeredinthefeed, ateitheroftwo
concentrations, to groups ofmale and female animals of
each species. The high and low dietary concentrations
used in the chronic bioassay were 0.012 and 0.006 per-
cent, respectively, for both species. After a 104-week
period of chemical administration, observation of rats
continued for up to 3 weeks and observation of mice
continuedforupto1week. Forrats50animalsofeachsex
wereplaced on testas controls,whileformice 55 animals
ofeach sex were placed on test as controls.
There were no significant positive associations
between the dietary concentration of 2,3,5,6-
tetrachloro-4-nitroanisole administered andmortalityin
rats or mice ofeither sex. Adequate numbers ofanimals
in all groups survived sufficientlylong tobe atrisk from
late-developing tumors.
No neoplasms, except for interstitial-cell testicular
tumors in males, occurred at statistically significant
incidences
Synonyms: 1-methoxy-4-nitro-2,3,5,6-tetrachloroben-
zene; tetrachloronitroanisole; ENT 33225; TCNA
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-115 Bioassay of Sulfallate for Possible
Carcinogenicity(CAS No.95-06-7)
Sulfallate, a chlorinated dithiocarbamate derivative
used as a preemergence herbicide on vegetable crops,
was selected for bioassay by the National Cancer
Institute because of its structural relationship to the
knowntumorigens selenium diethyldithiocarbamate and
potassiumbis(2-hydroxyethyl) dithiocarbamate and to a
number of suspected tumorigens containing the
diethyldithiocarbamate or dimethyldithiocarbamate
moieties.
A bioassay for possible carcinogenicity of sulfallate
was conducted using Osborne-Mendel rats and B6C3F1
mice. Sulfallatewas administeredinthefeed, ateitherof
two concentrations, to groups of 50 male and 50 female
animals ofeach species. Twentymice and 50 rats ofeach
sexwere placed on test as controls for the bioassay. The
time-weighted average high and low dietary concentra-
tions ofsulfallatewere, respectively, 410 and 250ppm for
malerats, 404 and250ppmforfemale rats, 1,897 and 949
ppm for male mice, and 1,815 and 908 ppm for female
mice.After a 78-weekperiod ofchemical administration,
there was an additional observation period of 25 to 26
weeks for dosed rats, 33 weeks for control rats, and 12 to
13 weeks for dosed and control mice.
There were significant positive associations between
increased sulfallate concentration and accelerated mor-
tality in both sexes ofrats and in female mice. However,
adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors.
Statistical analyses of the incidences of mammary
adenocarcinomas infemale rats, stomachneoplasms (i.e.,
combination of papillomas NOS, squamous-cell
papillomas, and squamous-cell carcinomas) in male rats,
combined alveolar/bronchiolar carcinomas and alveolar/
bronchiolar adenomas in male mice, and adenocar-
cinomas ofthemammaryglandinfemalemicerevealed a
significant positive association between dosage and inci-
dence. These associations were all supported by at least
one significant Fisher exact comparison.
The incidences oftoxic tubular nephropathy observed
in male rats and in mice ofboth sexes increased with the
concentration of the compound administered. This non-
neoplastic lesion was not observed in control animals.
Under the conditions ofthis bioassay, dietary admin-
istration of sulfallate was carcinogenic to Osborne-
Mendel rats and to B6C3F1 mice, inducing mammary
gland tumors in females of both species, tumors of the
forestomach in male rats, and lung tumors in male mice.
Synonyms: diethylcarbamodithioic acid 2-chloro-2-
propenyl ester; 2-chloro-2-propenyl diethylcar-
bamodithioate; 2-chloroallyl diethyldithiocarbamate;
diethyldithiocarbamic acid 2-chloroallyl ester; CDEC;
CP4742
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
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TR-116 Bioassay of p-Anisidine
Hydrochloride for Possible Carcinogenicity
(CASNo. 20265-97-8)
p-Anisidine hydrochloride, thehydrochloride saltofan
aromatic dye intermediate, was selected for bioassay by
the National Cancer Institute because of the increased
bladdercancerincidence notedamongworkersinthedye
manufacturing industry.
A bioassay for possible carcinogenicity ofp-anisidine
hydrochloride was conducted using Fischer344 rats and
B6C3F1 mice. p-Anisidine hydrochloride was admin-
istered in the feed, at either of two concentrations, to
groups of55 male and 55 female animals ofeach species.
Fifty-five animals ofeach sexand species were placed on
test as controls. Thehigh and lowdietaryconcentrations
of p-anisidine hydrochloride were, respectively, 0.6 and
0.3 percent for rats and 1.0 and 0.5 percent formice. The
compound was administered in the diet for 103 weeks,
followed by an observation period of2 to 3weeks forrats
and 2 weeks for mice.
There were no significant positive associations for
either species between the concentration of p-anisidine
hydrochloride administered and mortality. In addition,
adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors.
In male rats there were significant associations
between compound administration and the incidences of
both squamous-cell carcinomas ofthe skin and alveolar/
bronchiolar adenomas. None of the Fischer exact com-
parisons, however, supported thesefindings.Whenthose
males having adenomas NOS or carcinomas NOS ofthe
preputial gland were combined and the resulting inci-
dences statistically analyzed, the only test providing a
significant resultwas the Fisherexactcomparison ofthe
lowdosetothecontrol. Therewerenosignificantpositive
associations between the administration of p-anisidine
hydrochloride and the incidence of any tumor in mice of
either sex.
Although, under the conditions ofthis bioassay, there
appeared to be an association between chemical admin-
istration and the increased incidence ofpreputial gland
tumors in low dose male rats, the evidence was insuffi-
cient to establish the carcinogenicity of p-anisidine
hydrochloride in Fischer344 rats.Thecompoundwas not
carcinogenic in B6C3F1 mice.
Synonyms: 4-methoxy-benzeneamine HCl; p-ami-
noanisole HCl; 4-methoxyaniline HCl
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
TR-117 Bioassay of 6-Nitrobenzimidazole
for Possible Carcinogenicity (CAS No.
94-52-0)
6-Nitrobenzimidazole, a heterocyclic aromatic com-
pound used in photographic developers, was selected for
bioassaybythe National Cancer Institute because ofthe
suspect status ofaromatic nitro- compounds.
A bioassay for possible carcinogenicity of 6-nitro-
benzimidazole was conductedusing Fischer344 rats and
B6C3F1 mice. 6-Nitrobenzimidazolewasadministeredin
the feed, ateither oftwo concentrations, to groups of50
male and 50 female animals ofeach species. The dietary
concentrations used in the chronicbioassaywere 0.5 and
0.12 percent for the high and low dose rats, respectively,
and 0.24 and 0.12 percentforthe high and low dosemice,
respectively.Aftera78-weekperiod ofcompound admin-
istration, observation of the rats continued for up to an
additional 29 weeks and observation of the mice con-
tinued for an additional 18 weeks. For each species and
each dosed group, 49 or 50 animals of each sex were
placed on test as controls.
There were no significant positive associations between
the administered dietary concentrations of 6-nitrobenzi-
midazole and mortality in either sex ofrats or mice. In all
groups adequate numbers ofanimals survived sufficiently
long to be at risk from late-developing tumors.
Among both male and female mice, the incidences of
hepatocellular carcinomas in high dose groups were
statistically significant relative to controls.
Among rats of both sexes, nonneoplastic lesions of the
eyesandoftheHarderianglandsappearedtobeassociated
with administration of 6-nitrobenzimidazole. No neo-
plasms, however,were attributed to compound administra-
tion.
Under the conditions ofthis bioassay, dietary admin-
istration of6-nitrobenzimidazole was not carcinogenic to
Fischer 344 rats; however, the compound was car-
cinogenic to B6C3F1 mice, causing hepatocellular car-
cinomas in both sexes.
Synonym: 5-nitro-lH-benzimidazole
Report Date: 1979
Levels ofEvidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Positive
Positive
TR-118 Bioassay of 5-Nitroacenaphthene
for Possible Carcinogenicity (CAS No.
602-87-9)
5-Nitroacenaphthene has never had any known com-
mercialapplicationintheUnitedStatesandisapparently
produced in this country solely for research purposes.
The compound is, however, used in Japan as a captive
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Equivocal
Negative
Negative
Negative
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intermediate in the synthesis of naphthalimide dyes; 95
percent of these dyes find application as fluorescent
whitening agents in laundry detergents while the
remainder are used to dye paper.
A bioassay of 5-nitroacenaphthene for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 5-Nitroacenaphthenewasadministeredin
the feed, at either oftwo concentrations, to groups of50
maleand50femaleanimals ofeach species. Formaleand
female rats, the high and low dietary concentrations of
5-nitroacenaphthene were 0.24 and 0.12 percent, respec-
tively. The high and low time-weighted average con-
centrations for mice were 0.12 and 0.06 percent,
respectively, formales and 0.12 and 0.05percent, respec-
tively, forfemales. After a 78-week dosingperiod, obser-
vation ofsurviving rats continuedforup to22weeks and
observation ofthe mice continued for 18 weeks.
For the chronic rat bioassay, 49 male and 50 female
ratswereplacedontestashighdosecontrols,and50rats
ofeach sex served as low dose controls. For the mice, 50
males and 50 females were placed on test as controls.
Accelerated mortality was observed in all dosed
groups except the low dose female mice. There was a
positive association between mortality and dietary con-
centration of5-nitroacenaphthene forboth sexes ofboth
species. Early deaths were most apparent among high
dose male mice; half of the animals in this group were
deadbyweek20andinsufficientmalemicesurvivedtobe
at risk from late-developing tumors.
Among rats, the incidence ofmalignant tumors ofthe
ear canal (incidences of ceruminous carcinomas and
squamous-cell carcinomas were combined) was signifi-
cant at each dose level in each sex. Among both dosed
groups of female rats, the incidence of clitoral gland
carcinoma and the incidence of mammary adenocar-
cinoma were significant. A significant incidence of
alveolar/bronchiolar carcinomawas observedinlowdose
rat groups ofeach sex.
Among female mice, the incidence of hepatocellular
carcinoma was significant at each dose level. The com-
bined incidence ofgranulosa-cell tumors, luteomas, and
tubular-cell adenomas ofthe ovarywas significantin the
high dose female mouse group.
Under the conditions of this bioassay, 5-nitro-
acenaphthenewascarcinogenictoFischer344rats, caus-
ing increased incidences ofmalignant tumors ofthe ear
canal andlunginboth sexes, andoftheclitoralgland and
mammary gland in females. 5-Nitroacenaphthene was
also carcinogenic to female but not male B6C3F1, mice,
causing carcinomas ofthe liver and ovarian tumors.
Synonyms: 1,2-dihydro-5-nitro-acenaphthylene; 5-nitro-
acenaphthylene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Positive
TR-119 Carbon Disulfide (CAS: 75-15-0)
Dataconsidered to be inconclusive and notreportable;
no Technical Report issued
TR-120 Bioassay ofPiperonyl Butoxide
for Possible Carcinogenicity (CAS No.
51-03-6)
Piperonyl butoxide is used to enhance the insecticidal
properties of the pyrethrins by blocking the pyrethrin
detoxification enzymes in the insect. Pyrethrins alone
produce a very rapid knockdown of insects followed by
substantial recovery, whereas addition of a synergist
such as piperonyl butoxide decreases the insecticidal
dose ofpyrethrin. Piperonyl butoxide is also formulated
withsyntheticpyrethrinanalogues, suchasallethrinand
tetramethrin.
A bioassay of technical-grade piperonyl butoxide for
possiblecarcinogenicitywasconductedbyadministering
the testchemicalin feed to Fischer344 rats andB6C3Fj
mice.
Groups of 50 rats of each sex were administered
piperonyl butoxide in the diet at one oftwo doses, either
5,000 or 10,000 ppm, for 107 weeks. Matched controls
consisted of20 untreated rats ofeach sex. All surviving
ratswerekilled attheend oftheperiod ofadministration
ofthe test chemical.
Groups of 50 mice of each sex were initially admin-
istered piperonyl butoxide at one of two doses, either
2,500 or5,000ppm.Afterweek30, the dosesforthemice
were reduced to 500 and 2,000 ppm, respectively, and
administration ofthe test chemical at the lowered doses
was continued for 82 weeks. The time-weighted average
doses for the mice were either 1,036 or 2,804 ppm.
Matched controls consisted of20 untreated mice ofeach
sex. All surviving mice were killed at the end of the
period ofadministration ofthe test chemical.
Meanbodyweights ofdosed groups ofratsandmice of
each sexwere lower than those ofcorresponding control
groups, and the depressions in body weights were dose
related. Survival ofthe rats and mice was unaffected by
the piperonyl butoxide and was 80% or greater in all
groups atweek 90 ofthe bioassay; thus, sufficient num-
bers ofdosed and control rats andmice ofeach sexwere
at risk for the development oflate-appearing tumors.
Infemale rats, lymphomas occurred atincidences that
were dose related (P =0.007); in a directcomparison, the
incidence ofthetumorinthehigh-dose groupwashigher
(P =0.020) than that in the control group (controls 1/20,
low-dose 7/50,high-dose15/50). However,theincidenceof
lymphomas, leukemias, and reticuloses in historical-
control female Fischer 344 rats at the same laboratory
was 19/191 (10%). These historical-control groups include
one with an incidence of animals with lymphoma or
leukemia of7/20 (35%) and anotherwith an incidence of
6/20 (30%). Thus, the incidence of lymphomas in the
controlfemaleratsofthepresentbioassaymayhavebeen
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abnormally low, and the occurrence of the higher inci-
dence in the dosed groups cannot be clearly related to
administration ofpiperonyl butoxide.
In the male mice, adenomas of the lacrimal gland
occurred atincidences thatwere doserelated (P=0.023),
butin direct comparisons theincidences intheindividual
dosed groups were not significantly higher than that in
thecontrolgroup(controls 0/20,low-dose0/49,high-dose
4/50); thus, the occurrence ofthis tumorinthemale mice
was not clearly related to administration of the test
chemical.
It is concluded that under the conditions of this bio-
assay, piperonyl butoxide was not carcinogenic for
Fischer 344 rats or B6C3F1 mice.
Synonym: 5-((2-(2-butoxyethoxy)ethoxy)-methyl-6-
propyl-1,3-benzodioxole
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-121 Bioassay ofDimethyl
Terephthalate for Possible Carcinogenicity
(CASNo.120-61-6)
Dimethyl terephthalate is one of the basic monomers
used in the synthesis ofpolyester fibers.
Abioassay ofdimethyl terephthalate for possible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered dimethyl terephthalate at one oftwo
doses, either 2,500 or 5,000 ppm, for 103 weeks, then
observed for 2 additional weeks. Matched controls con-
sisted of50 untreated rats ofeach sex and 50 untreated
mice ofeach sex. All surviving rats were killed at 105 or
106 weeks and all surviving mice at 104 or 105 weeks.
Administration of dimethyl terephthalate had no
appreciable effect on the mean body weights ofthe rats
andmice ofeithersex. Noclinical signs related to admin-
istration of the test chemical -were noted in the rats.
Survivals ofthe rats and mice at the end ofthe bioassay
were notaffected bythe test chemical. Both species may
have been able to tolerate higher doses.
In rats and mice of each sex, no tumors occurred at
incidences that clearly were related to administration of
the test chemical.
Although it is recognized that both rats and mice may
not have received a dose ofthe test chemical sufficiently
high to provide maximum test sensitivity, itis concluded
that under the conditions of this bioassay, dimethyl
terephthalate was not carcinogenic for F344 rats or
B6C3F1 mice.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Equivocal
Negative
TR-122 Bioassay ofDibenzo-p-dioxin for
Possible Carcinogenicity (CAS No.
262-12-4)
Unsubstituted dibenzo-p-dioxin (UDD),is ananalogof
a series of chlorinated dibenzo-p-dioxins that were
selected forcarcinogenesistesting. Thechlorinated com-
pounds are formed as unwanted by-products during the
synthesis of chlorophenols, and were discovered in the
late 1960's as contaminants in the industrial microbicide
pentachlorophenol, and in a widely used agricultural
herbicide, 2,4,5-trichlorophenoxyacetic acid (2,4,5-T).
A bioassay of UDD for possible carcinogenicity was
conducted by administering the test chemical in feed to
Osborne-Mendel rats and B6C3F1 mice.
Groups of35 rats ofeach sexwere administered UDD
at one of two doses, either 5,000 or 10,000 ppm, for 110
weeks. Groups of50 mice ofeach sex were administered
the same doses for 87 or 90weeks. Controls consisted of
groups of35untreated rats ofeach sex and 50 untreated
miceofeachsex.Allsurvivingmaleratswerekilledat110
weeks, all surviving male mice at 92 to 97 weeks, and all
surviving female mice at 91 to 93 weeks.
Mean bodyweights ofthe dosed male and female rats
and mice were lower than those of the corresponding
controls; the depression in the amount ofweight gained
in the dosed male mice was, however, relatively slight.
Except for the male rats, survival at the end of the
bioassay was lower in the dosed groups ofboth rats or
mice than in the corresponding control groups. Atweek
90, atleast57% ofthe rats and 54% ofthe micewere still
alive. Because the meanbodyweights and survival rates
of the dosed animals were lower than those of corres-
ponding controls and because there was an increase in
the incidence ofhepatotoxic lesions, the 10,000-ppm con-
centration administered to the rats and mice is consid-
ered to be the maximum tolerated dose.
No tumorswereinducedin rats ormice ofeither sex at
incidences that were significantly higher in the dosed
groups than in the corresponding control groups.
It is concluded that under the conditions of this bio-
assay, UDD was not carcinogenic for Osborne-Mendel
rats or B6C3F1 mice.
Synonym: UDD
Report Date: 1979
Levels ofEvidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
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TR-123 Bioassay of2,7-Dichlorodibenzo-
p-dioxin (DCDD) for Possible
Carcinogenicity (CAS No. 33857-26-0)
2,7-Dichlorodibenzo-p-dioxin, referred to in this
report as DCDD, is a chlorinated dibenzodioxin. Chlori-
nated dibenzodioxins have been found as by-products in
the manufacture of pentachlorophenol and in the her-
bicide 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its
esters. Pentachlorophenol is a microbicidal agent that is
used as a wood preservative, for slime control in her-
bicide formulations, and in the manufacture of paper
pulp; 2,4,5-T has been used as a herbicide on national
forests, rangelands, pastures, in the agricultural indus-
try, and as a component of Agent Orange, a wartime
defoliant.
Abioassay ofDCDD for possible carcinogenicity was
conducted by administering the test chemical in feed to
Osborne-Mendel rats and B6C3F1 mice.
Groups of 35 rats of each sex were administered
DCDD atoneoftwodoses,either5,000or10,000ppm,for
110 weeks. Groups of 50 mice of each sex were admin-
istered these same doses for 90 weeks. Controls con-
sisted of35 untreated rats ofeach sex and 50 untreated
miceofeachsex.Allsurvivingmaleratswerekilledat110
to112weeks, allsurvivingfemalerats at110to 117weeks,
all surviving male mice at 92 to 101 weeks, and all
surviving female mice at 91 to 98 weeks.
Meanbodyweights ofmostofthedosed groups ofrats
and mice were lower than those of corresponding con-
trols both when placed on study and for much of the
study period; however, survival of any group was not
significantlyaffectedbyadministration ofthe testchem-
ical. Sufficient numbers of dosed and control rats and
mice ofeach sexwere atrisk forthe development oflate-
appearing tumors.
No tumors were induced in male or female rats or
female mice at incidences that were significantly higher
in the dosed groups than in the corresponding control
groups. Both low- and high-dose rats had toxic hepatic
lesions characterized by centrilobular fatty meta-
morphosis and/or necrosis.
In the male mice, hepatocellular adenomas or car-
cinomas occurred at incidences that were dose related
(P=0.008), and,indirectcomparisons,werehigherinthe
low-dose group (P = 0.008) and the high-dose group
(P=0.010) than in the control group (controls 8/49, low-
dose 20/50, high-dose 17/42). However, the historical
incidence of this lesion in control male B6C3F1 mice at
this laboratory does notpermit a clear association ofthe
lesion with the administration of the test compound.
There were also significant increases in the incidence of
combinations of leukemias and lymphomas and of
hemangiosarcomas and hemangiomas in the low-dose
male mice, but these findings were not supported bythe
high-dose animals.
It is concluded that under the conditions of this bio-
assay, DCDD was not carcinogenic for Osborne-Mendel
rats ofeither sex orforfemale B6C3F1 mice. Themargi-
nal increased incidences of combinations of leukemias
and lymphomas, of hemangiosarcomas and hemangio-
mas, and ofhepatocellular carcinomas and adenomas in
male B6C3F1 mice are, however, considered as sug-
gestive of a carcinogenic effect of 2,7-dichlorodibenzo-
p-dioxinin these animals.
Synonym: DCDD
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Equivocal
Female Mice: Negative
TR-124 Bioassay ofPiperonyl Sulfoxide
for Possible Carcinogenicity (CAS No.
120-62-7)
Piperonyl sulfoxide is used to enhance the insecticidal
properties of the pyrethrins by inhibiting pyrethrin
detoxification enzymes,probablymicrosomal oxidases,in
the insect. Pyrethrins alone produce a transient paral-
ysis,whereaspyrethrins combinedwith asynergist such
as piperonyl sulfoxide are insecticidal.
A bioassay of technical-grade piperonyl sulfoxide for
possiblecarcinogenicitywasconductedbyadministering
the testchemicalinfeed to Fischer344 rats andB6C3Fj
mice.
Groups of 50 rats of each sex were administered
piperonyl sulfoxide in the diet at one of several doses,
either1,500or3,000ppmforthemalesandeither3,000or
6,000 ppm for the females, for 105 weeks. Matched con-
trols consisted of 20 untreated rats of each sex. All
surviving rats were killed at the end of the period of
administration ofthe test chemical.
Groups of50 male mice were administered one oftwo
doses,either350or700ppm,for104 or105weeks.Groups
of50 female mice were initially administered one oftwo
doses, either 700 or 1,400 ppm. Due to excessive weight
depression in the dosed female mice, the doses for this
sex were reduced after week 20 to 200 and 600 ppm,
respectively, and administration of the test chemical at
the lower doses was continued for 84 or 85 weeks. The
time-weighted average doses for the females were 295
and 754ppm. Matchedcontrolsconsisted of20untreated
miceofeach sex.Allsurvivingmicewerekilledattheend
ofthe period ofadministration ofthe test chemical.
Meanbodyweightsofdosedgroupsofratsandmiceof
each sexwere lower than those ofcorrespondingcontrol
groups, and the depressions in the amount ofmean body
weight gained were dose related for most or all of the
bioassay; the depression in the amount of mean body
weight gained was slight, however, in the dosed male
rats. Survival ofthe rats and micewas unaffected bythe
piperonylsulfoxideandwas78%orhigherinallgroupsat
week90 ofthebioassay;thussufficientnumbersofdosed
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and control rats and mice ofeach sexwere atriskforthe
development oflate-appearing tumors.
In the male and female rats and in the female mice, no
tumors occurred at incidences that were significantly
higher in dosed groups than in control groups.
In the male mice, hepatocellular carcinomas occurred
at incidences that were dose related (P<0.001); in direct
comparisons, the incidence of these tumors in the high-
dose group was significantly higher (P<0.001) than that
in the control group (controls 6/18, low-dose 31150, high-
dose 46/50).
It is concluded that under the conditions of this bio-
assay, technical-grade piperonyl sulfoxide was not car-
cinogenic for male or female Fischer 344 rats or for
female B6C3F1 mice, but was carcinogenic for male
B6C3F1 mice, producing an increased incidence of
hepatocellular carcinomas.
Synonym: 1,2-(Methylenedioxy)-4-(2-(octylsulfinyl) pro-
pyl) benzene.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-125 Bioassay ofDioxathion for
Possible Carcinogenicity (CAS No. 78-34-2)
Dioxathion, an organophosphorous insecticide, was
selected for bioassay by the National Cancer Institute
because of its widespread use on livestock and edible
crops, and a lack ofadequate chronic toxicity data.
A bioassay for possible carcinogenicity of technical-
grade dioxathion was conducted using Osborne-Mendel
and B6C3F1 mice. Dioxathion was administered in the
feed, ateither oftwo concentrations, to groups of50male
and 50 female animals ofeach species. The high and low
time-weighted average concentrations were, respec-
tively,180 and 90ppmformalerats and90and45ppmfor
female rats. The high and low time-weighted average
concentrations for male mice were 567 and 284 ppm,
respectively, and for female mice were 935 and 467 ppm,
respectively. After a 78-week period of chemical admin-
istration, observation of the rats continued for an addi-
tional 33 weeks and the mice were observed for an
additional 12 to 13weeks. Forrats, 50 animals ofeach sex
wereplaced ontestascontrols andfedonlythebasaldiet,
while formice, 20 animals ofeach sex served as controls.
Inboth species adequate numbers ofanimals survived
long enough to be at risk from late-appearing tumors.
A variety of neoplasms was observed in treated ani-
mals of both species; however, none of the neoplasms
observed were either histopathologically unusual or in
statistically significant incidences.
Under the conditions ofthis bioassay, dietary admini-
istration ofdioxathion was not carcinogenic in Osborne-
Mendel rats or B6C3F1 mice.
Synonyms: phosphorodithioic acid, S,S'-p-dioxane-2,3-
diyl O,O,O',O'-tetraethyl ester; 2,3-p-dioxanedithiol S,S-
bis(O,O-diethyl phosphorodithioate; phosphorodithioic
acid, S,S'-1,4-dioxane-2,3-diyl O,O,O',O'-tetraethyl ester
Report Date: 1978
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-126 Bioassay of2,5-Toluenediamine
Sulfate for Possible Carcinogenicity (CAS
No.6369-59-1)
2,5-Toluenediamine sulfate, a salt of 2,5-toluene-
diamine and sulfuric acid, was selected for bioassay by
the National Cancer Institutein an attemptto determine
thosedyeintermediateswhichmayberesponsibleforthe
increased incidence of bladder cancer observed among
workers in the dye manufacturing industry. Aromatic
amines are one ofseveral classes ofchemicals thoughtto
contribute to the increased cancer risk in this industry.
A bioassay for possible carcinogenicity of 2,5-
toluenediamine sulfate was conducted using Fischer 344
rats and B6C3F1 mice. 2,5-Toluenediamine sulfate was
administered in the feed, at either oftwo concentrations,
to groups of50males and 50females ofeach species. The
high and low time-weighted average concentrations of
the compoundwere, respectively, 0.2 and 0.06percentfor
rats and 0.1 and 0.6 percent for mice. Because compound
administration to the high and low dose groups of each
species was notbegun simultaneously, each dosed group
was assigned a control group. All control groups con-
sisted of 50 animals, except for the high dose male and
female rat control groups which were composed of 25
animals. The dosingperiodwasfor 78weeks, followedby
an additional 28 to 31weeks ofobservation in rats and an
additional 16 to 19 weeks in mice.
There was no significant association between com-
pound administration and acceleratedmortalityin either
sex ofeither species. Adequate numbers ofanimals in all
groups survived sufficiently long to be at risk from late-
developing tumors.
A statistically significant incidence of interstitial-cell
neoplasms of the testis in dosed male rats was not
considered attributable to administration of the com-
pound since the spontaneous incidence of these neo-
plasmsinmaleFischer344ratsisbothhighandvariable.
No neoplasms were observed in female rats at statis-
tically significant incidences.
A statistically significant increase in lung tumors in
high dose female mice was not considered convincing
evidence of a compound-related carcinogenic effect be-
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cause high dose male mice were received in separate
shipments from their controls and housed in separate
rooms from their controls.
Under the conditions of this bioassay, sufficient evi-
dence was not obtained to demostrate the carcino-
genicity og 2,5-toluenediamine sulfate in either Fischer
344 rats or B6C3F1 mice.
Synonyms: 2-methyl-1,4-benzenediamine sulfate;
p-tolylenediamine sulfate; p-diaminotoluene sulfate;
Fouramine standard; C.I. Oxidation base 4
Report Date: 1978
Levels ofEvidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-127 Bioassay of 5-Nitro-o-anisidine
for Possible Carcinogenicity (CAS No.
99-59-2)
5-Nitro-o-anisidine, a tri-substituted benzene deriva-
tiveused as anintermediate inthesynthesis ofdyes,was
selected for bioassay by the National Cancer Institute
along with other dye intermediates in an attempt to
determine which chemicals may be responsible for the
increased incidence of bladder cancer observed among
workers in the dye manufacturing industry. Aromatic
amines and amino compounds arethroughtto contribute
to the increased cancer risk in this industry.
A bioassay of 5-nitro-o-anisidine for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 5-Nitro-o-anisidine was administered in
the feed at either oftwo concentrations, to groups of50
male and 50 female animals ofeach species. The dietary
concentrations used in the chronic bioassay for low and
high dose rats were 0.4 and 0.8 percent, respectively.
DoseAand B micewerefed dietaryconcentrations of0.8
and 1.6 percent when initially placed on test, but after
week15theconcentrationfedtodose Bmicewasreduced
to 0.4percent.Aftera78-weekperiod ofchemical admin-
istration, observation of rats continued for up to an
additional 28 weeks and observation of mice continued
for up to an additional 19 weeks. For each species, 50
animalsofeach sexwereplaced ontestascontrolsforthe
group receiving the higher concentration and 49 to 50
animals were ofeach sexwere placed on test as controls
for the group receiving the lower concentration.
In both species, adequate numbers of animals in all
groups survived long enough to be at risk from late-
developing tumors.
Feeding of 5-nitro-o-anisidine to rats was associated
with increased incidences of tumors of the integumen-
tary system. Basal-cell carcinomas, trichoepitheliomas,
squamous-cell carcinomas and sebaceous adenocar-
cinomas each occurred inthe skin ofhigh dose male rats
at statistically significant incidences. For both male and
female rats, carcinomas (the combined incidence of
sebaceous adenocarcinomas, ceruminous carcinomas
and squamous-cell carcinomas) ofthe Zymbal's gland or
the skin of the ear were significant in the high dose
groups. In the clitoral gland of dosed female rats, the
incidence of carcinomas and the incidence of adenomas
were each significant.
Amongmice,theincidenceofhepatocellularcarcinoma
was statistically significant for dose B females when
compared to their appropriate controls.
Under the conditions ofthis bioassay, dietary admin-
istration of 5-nitro-o-anisidine was carcinogenic in
Fischer 344 rats, causing tumors of the integumentary
system in males and females and ofthe clitoral gland in
females. The compound was also carcinogenic to female
B6C3F1 mice, causing hepatocellular carcinomas.
Synonyms: 2 - methoxy - 5 - nitro - benzeneamine; 3 -
amino-4-methoxy-nitrobenzene; 2-methoxy-5-nitroani-
line; 2-amino-4-nitroanisole; Fast Scarlet R; C.I. Azoic
Diazo Component 13
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Positive
Positive
Equivocal
Positive
TR-128 Bioassay of3,3'-
Dimethoxybenzidine-4,4'-diisocyanate for
Possible Carcinogenicity (CAS No. 91-93-0)
3,3'-Dimethoxybenzidine-4,4'-diisocyanate, a dimer of
o-anisidine-4,4'-diisocyanate, was selected for bioassay
by the National Cancer Institute because of the struc-
tural similarity of this compound to 3,3'-
dimethoxybenzidine, a carcinogen in Fischer rats.
A bioassay for the possible carcinogenicity of 3,3'-
dimethoxybenzidine-4,4'-diisocyanate was conducted
using Fischer 344 rats and B6C3F1 mice. 3,3'-
Dimethoxybenzidine-4,4'-diisocyanate was admin-
istered, at either of two concentrations, to groups of 50
male and 50 female animals of each species, with the
exception of49high dosefemale rats. Thecompoundwas
administered inthefeedwiththeexceptionofthefirst22
weeks ofthe rat bioassay, when it was administered by
gavage. Twenty animals of each sex and species were
placedontestascontrols. Duringintubationthehighand
low dosages were 3,000 and 1,500 mg/kg, respectively,
while the high and low concentrations administered in
the feed to both rats and mice were 44,000 and 22,000
ppm, respectively. The compoundwas administered for a
period of78 weeks, followed by an observation period of
26 weeks for rats and 25 weeks for mice.
There was a significant positive association between
the administration of 3,3'-dimethoxybenzidine-4,4'-
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diisocyanate and mortality in male and female rats, but
notinmale orfemalemice.Adequate numbers ofanimals
in all groups survived sufficiently long to be at risk from
late-developing tumors.
For both sexes ofrats, there was a significant positive
association between dosage and the incidence of leuke-
mia and malignant lymphoma. There was a significantly
higherincidence ofneoplasms ofthe skin, excluding skin
of the ear, when dosed male rats were compared to
controls. There was a significant positive association
between the dosages administered and the incidences of
endometrial stromal polyps in female rats. None of the
statistical tests for any site in male and female mice
indicated a significant positive association between com-
pound administration and tumor incidence.
Under the conditions of this bioassay, administration
of 3,3'-dimethoxybenzidine-4,4'-diisocyanate was car-
cinogenic to Fischer 344 rats, causing neoplasms of the
skin (excluding skin of the ear) in males, endometrial
stromal polyps in females, and leukemia and malignant
lymphoma in both sexes. The compound was also associ-
atedwith the development ofacombination ofsquamous-
cell carcinomas and sebaceous adenocarcinomas of the
Zymbal's gland and skin ofthe ear in rats ofboth sexes.
There was no evidence of the carcinogenicity of the
compound in B6C3F1 mice.
Synonyms: 4,4'-diisocyanato-3,3'-dimethoxy-1,1'-bi-
phenyl; dianisidine diisocyanate; isocyanic acid 3,3'-
dimethoxy-4,4'-biphenylene ester; 4,4'-diisocyanato-3,3'-
dimethoxy-4,4'-biphenyl diisocyanate; 3,39-
dimethoxy-4,4'-biphenylene diisocyanate
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-129 Bioassay of Trimethylthiourea for
Possible Carcinogenicity (CAS No.
2489-77-2)
Trimethylthiourea, useful in a wide variety of indus-
trial applications, was selected for bioassay by the
National Cancer Institute because it is a derivative of
thiourea, a liver carcinogen in Osborne-Mendel rats.
A bioassay for the possible carcinogenicity of tri-
methylthiourea was conducted using Fischer 344 rats
and B6C3F1 mice. A mixture containing 80 percent
trimethylthiourea and 15 percent dimethylthiourea was
administered in the feed, at either oftwo concentrations,
to groups of 50 male and 50 female animals of each
species. Twenty animals of each sex and species were
placed on test as controls. The high and low dietary
concentrations of trimethylthiourea were, respectively,
500 and 250ppmforrats and 1,000 and 500ppmformice.
The compoundwas administered inthe dietfor77weeks,
followed by an observation period of 29 weeks for rats
and 14 weeks for mice.
There were no significant positive associations
between the dosage of trimethylthiourea administered
and mortality in rats or mice of either sex. Adequate
numbers of animals in all groups survived sufficiently
long to be at risk from late-developing tumors. For high
dose female rats and for dosed mice of both sexes,
compound-related mean body weight depression was
observed, indicating that the dosages of tri-
methylthiourea administered to these animals may have
approximated the maximum tolerated dosages. Since no
mean body weight depression relative to controls, no
significant accelerated mortality, and no other signs of
toxicity were associated with administration of tri-
methylthiourea to male rats, it is possible that these
animals may have been able to tolerate a higher dietary
concentration.
The incidences offollicular-cell carcinomas ofthe thy-
roid in female rats were dose-related, and there was a
significant difference between the incidences in the high
dose and control. This same relationship was established
for the combination of follicular-cell carcinomas and
follicular-cell adenomas in female rats.
Under the conditions of this bioassay, dietary admin-
istration oftrimethylthiourea was carcinogenic in female
Fischer 344 rats, inducing follicular-cell carcinomas of
the thyroid. There was not sufficient evidence for the
carcinogenicityofthe compound inmaleFischer344 rats
or in B6C3F1 mice of either sex.
Synonyms: trimethylthiourea, N,N,N'-trimethyl-
thiourea; 1,1,3-trimethyl-2-thiourea
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-130 Bioassay ofAniline
Hydrochloride for Possible Carcinogenicity
(CAS No.142-04-1)
Aniline hydrochloride, a dye intermediate and a com-
mercially important salt of aniline, was selected for
bioassaybythe National Cancer Institute because ofthe
increased incidence ofbladder cancer among workers in
the dye manufacturing industry and the historical asso-
ciation of aromatic amines with this increased cancer
risk.
A bioassay of aniline hydrochloride for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice.Anilinehydrochloridewas administeredin
the feed, at either oftwo concentrations, to groups of50
male and female animals ofeach species, with the excep-
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tion of49 female mice in the high dose group. The high
and low dietary concentrations of aniline hydrochloride
were,respectively,0.6 and0.3percentforratsand1.2and
0.6 percent for mice. After a 103-week period of com-
pound administration, observation of the rats and mice
continued for up to an additional 5 weeks.
For rats and mice, respectively, 25 and 50 animals of
each sexwere placed on test as controls and fed onlythe
basal diet.
In male rats there were several types ofmesenchymal
tumors, primarily ofthe spleen, associated with admin-
istration of the compound. Hemangiosarcomas of the
spleen and the combined incidence offibrosarcomas and
sarcomas NOS of the spleen were each statistically
significant inmale rats. The combined incidence offibro-
sarcomas and sarcomas NOS of multiple body organs
was also significant in male rats. The number offemale
ratshavingfibrosarcomas orsarcomasNOSofeitherthe
spleen alone or multiple organs of the body cavity was
significantly associated with increased dietary con-
centration of aniline hydrochloride. This reslult was not
supported by the Fischer exact tests, but because ofthe
rarity ofthese tumors, the observed incidences (0/24 in
the control group, 1/50 [2 percent] in the low dose group,
7/50 [14percent] inthehigh dosegroup)were considered
indicative ofa compound-related carcinogenic effect.
In mice of both sexes no tumors occurred in statis-
tically significant increased incidences among dosed
groups when compared to controls.
Under the conditions ofthis bioassay, dietary admin-
istration of aniline hydrochloride was carcinogenic to
maleandfemale Fischer344rats,inducinghemangiosar-
comas and a combination offibrosarcomas and sarcomas
NOS of the spleen and a combination of fibrosarcomas
and sarcomas NOS ofmultiple body organs. There was
no evidence of compound-induced carcinogenicity in
B6C3F1 mice ofeither sex.
Synonyms: hydrochloride benzeneamide; aniline salt;
aniline chloride
Report Date: 1978
Levels of Evidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-131 Bioassays ofDDT, TDE, and p,p'-
DDE for Possible Carcinogenicity (CAS
No. 50-29-3, CAS No. 72-54-8, CAS No.
72-55-9)
DDT is the common name for the technical product of
whichp,p'-DDTisthepredominant component. The com-
pound is asynthetic, chlorinatedhydrocarboninsecticide
which has broad-spectrum insecticidal activity. After
being used commercially and in large quantities in the
United Statesformorethantwo decades,its status as an
insecticide began to fade in the mid-1960swhen environ-
mentalists detected a possible link between DDT and
various ecological disturbances including the decline of
selected bird populations and numerous instances offish
kills.
TDE was introduced commercially in the United
States in 1945 shortly after the introduction of DDT.
Although lacking the broad-spectrum insecticidal
activity of DDT, TDE does possess equal or greater
potency against the larvae of some mosquitos and lep-
idoptera.
Bioassays of technical-grade DDT, TDE, and p,p'-
DDE for possible carcinogenicity were conducted using
Osborne-Mendel rats and B6C3F1 mice. Each compound
was administered in the feed, ateither oftwo concentra-
tions, to groups of50male and 50female animals ofeach
species. Twenty animals of each species and sex were
placed on test as controls for the bioassay ofeach com-
pound. The time-weighted average high and low dietary
concentrations of DDT were, respectively, 642 and 321
ppm for male rats, 420 and 210 ppm for female rats, 44
and22 ppmformalemice, and175 and 87ppmforfemale
mice. The time-weighted average high and low dietary
concentrations ofTDEwere,respectively,3,294 and1,647
ppmformalerats, 1,700 and850ppmforfemalerats, and
822 and 411 ppm for male and female mice. The time-
weighted average high and lowdietaryconcentrations of
DDE were, respectively, 839 and 437 ppm for male rats,
462 and 242ppmforfemalerats, and261and 148ppmfor
male and female mice. After the 78-week dosing period
there was an additional observation period of up to 35
weeks for rats and 15 weeks for mice.
There were significant positive associations between
increased chemical concentration and accelerated mor-
talityinfemalemicedosedwithDDTandinboth sexesof
rats and in female mice dosed with DDE. This associa-
tion was not demonstrated in other groups. There was,
however, poor survival among control and dosed male
miceusedinthebioassays ofDDTand DDE. In all cases
adequate numbers of animals in all groups survived
sufficiently long to be at risk from late-developing
tumors.
When those male rats receiving TDE and their con-
trolswerecombinedwithineachgroupsothatthenumer-
ators ofthe tumorincidences represented those animals
with either a follicular-cell carcinoma or a follicular-cell
adenoma of the thyroid, the incidence in the low dose
group was significantly higher than that in the controls.
There was a significant positive association between the
concentrationofDDE administeredandtheincidencesof
hepatocellular carcinomas in male and female mice.
Amongdosedratsandmiceno otherneoplasms occurred
in statistically significant incidences when compared to
their respective control groups.
Under the conditions ofthese bioassays there was no
evidence for the carcinogenicity of DDT in Osborne-
Mendel rats orB6C3F1 mice, ofTDE infemale Osborne-
Mendel rats orB6C3F1 miceofeithersex, orofp,p'-DDE
in Osborne-Mendel rats, although p,p'-DDE was hepato-
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toxic in Osborne-Mendel rats. The findings suggest a
possible carcinogenic effect of TDE in male Osborne-
Mendel rats, based on the induction of combined
follicular-cell carcinomas and follicular-cell adenomas of
the thyroid. Because ofthe variation ofthese tumors in
control male rats in this study, the evidence does not
permit a more conclusive interpretation ofthese lesions.
p,p'-DDE was carcinogenic in B6C3F1 mice, causing
hepatocellular carcinomas in both sexes.
SynonymsforDDT:1,1'-(2,2,2-trichloroethylidene) bis(4-
chloro)-benzene; 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-
ethane; p,p'-dichlorodiphenyltrichloroethane
Synonyms for TDE: 1,1'-(2,2-dichloroethylidene) bis(4-
chloro)-benzene; 1,1-dichloro-2,2-bis(p-chlorophenyl)-
ethane; p,p'-dichlorodiphenyldichloroethane
Synonyms for p,p'-DDE: 1,1'-(2,2-dichloroethenylidine)
bis(4-chloro)benzene; 1,1-dichloro-2,2-bis(p-chloro-
phenyl)-ethylene; p,p'-dichlorodiphenyldichloroethylene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
For p,p'-DDE (72-55-9):
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Positive
For DDT (50-29-3):
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
For TDE (72-54-8):
Male Rats: Equivocal
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-132 Bioassay of2,5-Dithiobiurea for
Possible Carcinogenicity (CAS No.
142-46-1)
2,5-Dithiobiurea, a component ofphotographic chemi-
cals, was selected for bioassay by the National Cancer
Institutebecauseitis a dimerofthiourea, aliver, thyroid
and Zymbal's gland tumorigen in rats.
A bioassay of 2,5-dithiobiurea for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 2,5-Dithiobiurea was administered in the
feed, ateither oftwoconcentrations, to groups of50male
and 50female animals ofeach species,withtheexception
ofhigh dose male rats, ofwhich there were only 49. The
dietary concentrations usedinthe chronicbioassaywere
0.6 percent for the low dose rats and 1.2 percent for the
high dose rats. The dietary concentrations used for low
andhigh dosemicewere1.0and2.0percent,respectively.
After a 78-week dosing period, observation of the mice
continuedforanadditional16weeks. Foreachspecies, 50
animals ofeach sex were placed on test as controls.
In both species, adequate numbers of animals in all
groups survived sufficiently long to be at risk from late-
developingtumors.Compound-relatedmeanbodyweight
depression was observed in mice but not in rats. No
consistentpatternofclinicalsignswasobservedineither
species.
Notumors occurred atasignificantlyhigherincidence
in dosed rats than in their controls. pmAmong female
mice, the Cochran-Armitage test indicated a significant
positiveassociationbetweentheincidenceofhepatocellu-
lar carcinoma and dietary concentrations of 2,5-
dithiobiurea. According to results of the Fisher exact
test, the incidence ofhepatocellular carcinoma was sig-
nificantly higher in the high dose female mouse group
when compared to the corresponding control group but
not when compared to the laboratory historical control
data. No neoplasms occurred at a significantly higher
incidence in dosed male mice than in their controls.
Under the conditions of this bioassay, the evidence
suggested, but was insufficient to establish the car-
cinogenicityof2,5-dithiobiureaforfemale B6C3F1 mice.
The compound was not carcinogenic to male B6C3Fj
mice or to male orfemale Fischer 344 rats.
Synonym: 1,2-hydrazinedicarbothioamide
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Equivocal
TR-133 Bioassay of3-Nitro-
p-Acetophenetide for Possible
Carcinogenicity (CAS No. 1777-84-0)
3-Nitro-p-acetophenetide, aderivative oftheanalgesic
phenacetin, was selected for bioassay by the National
Cancer Institute because of the suspected renal pelvic
carcinogenicity ofthe parent compound.
A bioassay for possible carcinogenicity of 3-nitro-
p-acetophenetide was conducted using Fischer 344 rats
and B6C3F1 mice. 3-Nitro-p-acetophenetide was admin-
istered in the feed, at either of two concentrations, to
groups of50 male and 50 female animals ofeach species,
with the exception oflow dose male mice, ofwhich there
were 49. Fifty animals of each sex and species were
placed on test as controls. The high and low time-
weighted average dietary concentrations of 3-nitro-
p-acetophenetide were, respectively, 0.36 and 0.18 per-
cent for rats and 1.46 and 0.73 percent for mice. The
compound was administered in the diet for 78 weeks,
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followed by an observation period ofup to 30 weeks for
rats and 20 weeks for mice.
There were no significant positive associations
between the concentrations of 3-nitro-p-acetophenetide
administered and mortalityin rats ormice ofeither sex.
In addition, adequate numbers of animals in all groups
survived sufficiently long to be at risk from late-
developing tumors.
There was a statistically significant increased inci-
dence ofacombination ofhepatocellular carcinomas and
adenomas when high dose male mice were compared to
controls. No other neoplasm in any other dosed group
occurred in significant positive increased incidences
when compared to controls.
Under the conditions ofthis bioassay, dietary admin-
istration of 3-nitro-p-acetophenetide was not car-
cinogenic in Fischer 344 rats of either sex or in female
mice. The compound, however, was considered car-
cinogenic in male B6C3F1 mice based on a significant
increase in the combined incidence of hepatocellular
carcinomas and hepatocellular adenomas in these ani-
mals.
Synonyms: N-(4-ethoxyphenyl)-3'-nitroacetamide; 3'-
Nitro-p-acetophenetide; 3'-Nitro-p-acetophenetidin;
4-Acetamino-2-nitrophenetole
Report Date: 1979
Levels ofEvidence of Carcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-134 Bioassay ofC.I. Vat Yellow 4 for
Possible Carcinogenicity (CAS No.
128-66-5)
C.I. vatyellow 4, a commercial formulation containing
dibenzo(b,def)chrysene-7,14-dione, is used bythe armed
services as a smokescreen and as a signaling agent.
Smoke dyeswereeffectivelyused tomaskthe movement
of troops in World War II and in Korea, where in some
instances men were exposed to chemical smokescreens
for several months.
A bioassay of C.I. vat yellow 4 for possible car-
cinogenicity was conducted by administering the test
chemical in feed to Fischer 344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered C.I. vat yellow 4 in the diet at one of
two doses, either 3,500 or 7,000 ppm for the rats, either
25,000 or 50,000 ppm for male mice, and either 12,500 or
25,000 ppm for the female mice. The rats were admin-
istered the test chemical for 104weeks; the mice, for 106
weeks. Matched controls consisted of 20 untreated rats
and 20untreated mice ofeach sex. All surviving animals
were killed at the end ofthe period ofadministration of
the test chemical.
Mean bodyweights ofthe dosed rats were lower than
thoseofcorrespondingcontrolsthroughoutthebioassay,
but the differences in weights were slight for the males.
Mean bodyweights ofthe dosed mice were not affected
by the test chemical. Survival ofthe rats and mice were
not affected adversely by the chemical, and sufficient
numbers ofdosed and control rats and mice ofeach sex
were at risk for the development of late-appearing
tumors.
In the male and female rats and the female mice, no
tumors occurred at incidences that were significantly
higher in dosed groups than in control groups.
In the male mice, lymphomas occurred at incidences
that were dose related (P=0.002) and, in a direct com-
parison, the incidence of the tumor in the high-dose
group was significantly higher (P=0.019) than that in
thecontrolgroup(controls3/20, or15%;low-dose7/47, or
15%; high-dose 22/50, or 44%). The incidence of lym-
phomasandleukemiasinhistorical-controlmaleB6C3Fj
mice, at this laboratory was 38/323 (12%).
It is concluded that under the conditions of this bio-
assay,theformulatedproductcontainingC.I.vatyellow4
was notcarcinogenic formale orfemale Fischer 344 rats
orforfemaleB6C3F1mice,butwascarcinogenicformale
B6C3F1 mice, causing an increased incidence of lym-
phomas.
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Positive
Female Mice: Negative
TR-135 Bioassay ofMalaoxon for
Possible Carcinogenicity (CAS No.
1634-78-2)
A bioassay ofmalaoxon, the oxygen analogue ofmal-
athion (anorganophosphateinsecticide), forpossible car-
cinogenicity was conducted by administering the test
chemical in feed to F344 rats and B6C3F1 mice.
Groupsof50ratsand50miceofeachsexwerefed diets
containing 500 or1,000-ppmmalaoxon for 103 weeks and
were then observed for up to an additional 2 weeks.
Matched controls consisted of groups of 50 untreated
rats and 50 untreated mice of each sex. All surviving
animals were killed at 103 to 105 weeks.
Theonlyeffectsthatcouldberelatedto administration
ofmalaoxon at the doses used were increased mortality
among male mice, decreased mean body weights of
female mice, gastric ulcers in male and female rats, and
possibly C-cell adenomas or carcinomas of the thyroid
among treated female rats. The incidence of C-cell ade-
nomas orcarcinomas amonghistorical controls, however,
precluded relating the incidence of these tumors to
administration ofthe chemical.
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It was concluded that under the conditions of this
bioassaymalaoxonwas not carcinogenic for F344 rats or
B6C3F1 mice.
Synonym: o,o-dimethyl S-1,2-bis(ethoxycarbonyl)ethyl
phosphorothioate
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-136 Bioassay ofAldicarb for Possible
Carcinogenicity (CAS No. 116-06-3)
The carbamate pesticide aldicarb is used for the con-
trolofinsects, nematodes, and mites. Itis nowregistered
for use on cotton, sugar beets, sugar cane, potatoes,
peanuts, and avariety offield- and nursery-grown orna-
mental plants.
Abioassay ofaldicarb forpossible carcinogenicitywas
conducted by administering the test chemical in feed to
F344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered aldicarb at one of two doses, either 2 or 6
ppm, for 103weeks and then observed for an additional 0
to 2 weeks. Matched controls consisted of 25 untreated
rats and 25 untreated mice of each sex. All surviving
animals were killed at weeks 103 to 105.
Mean bodyweights ofthe dosed male and female rats
were essentially the same as those ofthe corresponding
controls. Mean body weights of the dosed male and
female mice also were essentially the same as those of
corresponding controls. Hyperactivity was noted in the
dosed groups of mice. Survival was not affected signifi-
cantly in dosed groups ofeither the rats or the mice and
was 72% orgreaterin all dosed orcontrol groups atweek
90. Sufficient numbers of animals were at risk for the
development oflate-appearing tumors.
No tumors occurred in either the rats or mice at
incidences that could clearlybe related to administration
ofthetestchemical. Inbothrats andmice,however, there
was no indication either through weight depression or
earlymortality thatmaximum tolerated dose levels were
used. Therefore, the studies may not have been con-
ducted using maximum sensitivity for the assessment of
the possible carcinogenicity of aldicarb.
It is concluded that under the conditions of this bio-
assay, technical-grade aldicarb was not carcinogenic for
F344 rats or B6C3F1 mice of either sex.
Synonym: 2-methyl-2-(methylthio)propionaldehyde
O-(methylcarbamoyl)oxime
Report Date: 1979
Levels of Evidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-137 Bioassay ofDiazinon for Possible
Carcinogenicity (CAS No. 333-41-5)
Diazinon is used as an organophosphate insecticide. It
wasmarketedfirstin1954 as aninsecticide and acaricide
and has been used since that time as a dust or spray in
agriculture, on rangeland and wasteland, in industrial
establishments, and in the home. Diazinon has also been
applied as a livestock spray or dip and has been admin-
istered in the feed to farm and domestic animals for the
control of ectoparasites.
Abioassayofdiazinonforpossiblecarcinogenicitywas
conducted by administering the test chemical in feed to
F344 rats and B6C3F1 mice.
Groups of 50 rats and 50 mice of each sex were
administered diazinon at one oftwo doses, either 400 or
800 ppm for the rats and either 100 or 200 ppm for the
mice, for 103 weeks and were then observed for an
additional 1 or 2 weeks. Matched controls consisted of
groupsof25untreatedratsand25untreatedmiceofeach
sex. All surviving animalswere killed atthe end of104 or
105weeks.
There was no appreciable effect of administration of
diazinon on mean body weights ofrats or mice ofeither
sex. Mortality was not increased in any of the dosed
groups of rats or mice, when related to that in the
corresponding controls, and survivalwas 84% or greater
in all dosed and control groups of animals at week 78.
Some hyperactivity was noted in the dosed groups of
both species; however, both the rats and mice may have
been able to tolerate higher doses. Sufficient numbers of
animals were at risk in all groups for the development of
late-appearing tumors.
No tumors occurred in any ofthe dosed groups ofrats
or mice of either sex at incidences that could clearly be
related to the administration of diazinon.
It is concluded that under the conditions of this bio-
assay, diazinon was not carcinogenic for F344 rats or
B6C3F1 mice ofeither sex.
Synonym: o,o-diethyl o-(2-isopropyl-6-methyl-4-
pyrimidinyl)phosphorothioate
Report Date: 1979
Levels of Evidence of Carcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
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TR-138 Bioassay ofSulfisoxazole for
Possible Carcinogenicity (CASNo.127-69-5)
Sulfisoxazole is an antimicrobial drugthatis a deriva-
tive of sulfanilamide. Although the use of sulfonamide
drugs has declined in the past few years due to the
emergence ofdrug-resistant strains ofbacteria and the
development of newer antimicrobial drugs with fewer
side effects, these compounds are still widelyprescribed
on achronic basis forthetreatment ofrecurrenturinary
tract infections and certain other infectious diseases.
Abioassayofsulfisoxazoleforpossiblecarcinogenicity
was conducted by administering the chemical bygavage
to Fischer 344 rats and B6C3F1 mice.
Groups of50 rats ofeach sex and 50 mice ofeach sex
were administered sulfisoxazole suspended in aqueous
0.5% carboxymethyl cellulose 7 days per week at one of
two doses, either 100 or 400 mg/kg body weight for the
rats and either 500 or 2,000 mg/kg for the mice. Vehicle
controls consisted ofgroups of50rats ofeach sexand 50
mice ofeach sexthatwere administeredonlytheaqueous
0.5% carboxymethyl cellulose. Untreated controls con-
sisted ofgroups of50ratsofeach sexand50miceofeach
sex. The dosed groups ofthe rats and mice were admin-
istered the chemical by gavage for 103 weeks, then
observed for 1 to 3 additional weeks; the vehicle-control
groupswere similarly administered 0.5% carboxymethyl
cellulose alone. All surviving rats andmicewerekilled at
weeks 104 to 106.
Mean body weights ofhigh-dose male rats and female
mice were slightly lower than those of corresponding
vehicle controls during the last 40 to 50 weeks of the
bioassay;meanbodyweightsofdosedfemaleratsandmale
mice were unaffected. Survival rates were unaffected by
thetestchemical, andadequatenumbersofanimalswereat
risk for the development oflate-appearing tumors.
Notumorsoccurredinthedosedgroupsofratsormice
ofeither sex at incidences that were significantly higher
than those ofthe vehicle-control groups.
It is concluded that under the conditions of this bio-
assay, sulfisoxazole was not carcinogenic for either
Fischer 344 rats or B6C3F1 mice.
Synonym: N1-(3,4-dimethyl-5-isoxazolyl)sulfanilamide
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-139 Bioassay of Triphenyltin
Hydroxide for Possible Carcinogenicity
(CASNo. 76-87-9)
Triphenyltin hydroxide, an organometallic compound
used as a fungicide and antifeeding compound for insect
control,wasselectedforbioassaybytheNationalCancer
Institute because ofits use on edible crops and a lack of
adequate chronic toxicity data.
A bioassay oftriphenyltin hydroxide for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. Triphenyltin hydroxide was administered
in the feed, at either oftwo concentrations, to groups of
50male and 50 female animals ofeach species. The high
and low concentrations of triphenyltin hydroxide were,
respectively, 75 and 37.5 ppm for rats and mice. After a
78-week period of compound administration, there was
an additional observation period of 26 weeks for both
species. Twenty animals of each sex and species were
placed on test as controls.
Formalemice,therewasasignificantpositiveassocia-
tion between dosage and mortality. In both species,
however, adequate numbers of animals survived suffi-
ciently long to be at risk from late-developing tumors.
Exceptfor a slight depression ofmeanbodyweightgain
in male rats and female mice, compound-related mean
body weight depression was not observed in either spe-
cies. In female rats no significant accelerated mortality,
retardation of growth, or other signs of toxicity were
associated with the dietary administration of tri-
phenyltin hydroxide. Therefore, it is possible that the
compound was not administered at the maximum toler-
ated concentrations.
No tumors occurred atasignificantlyhigherincidence
in dosed rats or mice than in controls.
Under the conditions of this bioassay, there was no
evidence for the carcinogenicity oftriphenyltin hydrox-
ide to Fischer 344 rats or B6C3F1 mice.
Synonyms: hydroxytriphenylstannane; hydrox-
ytriphenyltin; fentin hydroxide; TPTH; TPTOH; ENT
2009
ReportDate: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats:
Female Rats:
Male Mice:
Female Mice:
Negative
Negative
Negative
Negative
TR-140 Bioassay ofPivalolactone for
Possible Carcinogenicity (CAS No.
1955-45-9)
Pivalolactone, anintermediateinpolymerpreparation,
was selected for bioassay by the National Cancer
Institute because of the structural similarity of this
compound to 3-propiolactone, a well documented direct
acting carcinogen.
The bioassay of pivalolactone for possible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. Pivalolactone in water was administered
by gavage, ateitheroftwo dosages, to groups of50male
and 50 female animals ofeach species. The high and low
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dosages ofpivalolactone utilized were, respectively, 300
and150mg/kg/dayforratsand 150and 75mg/kg/dayfor
mice. After a 103-week period ofcompound administra-
tion for rats and a 102-week period ofcompound admin-
istration for mice, rats were observed for 2 additional
weeks and micefor1 additionalweek. Twentyanimals of
each sex and species were placed on test as vehicle
controls.
There was no significant positive association between
dosage and mortality for either rats ormice, and inboth
species, adequate numbers of animals survived suffi-
ciently long to be at risk from late-developing tumors.
Compound-relatedmeanbodyweightdepressionwasnot
observed in either sex of either species. In addition, no
adverse clinical signs were observed among dosed mice.
This evidence, plus the relatively fast decomposition of
pivalolactone in water, suggests the possibility that the
animals, andinparticularthemice,mayhavebeenableto
tolerate a higher dose.
Statistically significant incidences of squamous-cell
papillomas and squamous-cell carcinomas of the for-
estomachwereobservedinratsbutnotinmice. Noother
rare or unusual tumors were observed in either species.
Under the conditions of this bioassay, pivalolactone
was found to be carcinogenic to both male and female
Fischer 344 rats, producing squamous-cell carcinomas
and squamous-cell papillomas of the forestomach. This
study provided no evidence for the carcinogenicity of
pivalolactone in B6C3F1 mice ofeither sex.
Synonyms: 3,3-dimethyl-2-oxethanone; 3,3-dimethyl-2-
oxetanone; 3,3-dimethyl-p-propiolactone; dimethyl pro-
piolactone; pivalic acid lactone
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Negative
Female Mice: Negative
TR-141 Bioassay of1-Phenyl-3-methyl-5-
pyrazolone for Possible Carcinogenicity
(CASNo.89-25-8)
1-Phenyl-3-methyl-5-pyrazolone, an aromatic hetero-
cycle andwidelyused dye intermediate, was selected for
bioassaybythe National Cancer Institutebecause ofthe
increased incidence of bladder cancer observed among
workers in the dye manufacturing industry.
A bioassay of 1-phenyl-3-methyl-5-pyrazolone for
possible carcinogenicity was conducted using Fischer
344 rats and B6C3F1 mice. 1-Phenyl-3-methyl-5-
pyrazolone was administered in thefeed, ateither oftwo
concentrations, to groups of49 or 50 male and 50 female
animals ofeachspecies. Thehighandlowconcentrations
of1-phenyl-3-methyl-5-pyrazolone utilized were, respec-
tively, 5,000 and 2,500 ppm for rats and 15,000 and 7,500
ppm for mice. Twenty animals of each species and sex
were placed on test as controls. After a 103-week period
of chemical administration, there was an additional
observationperiodof2weeksforrats.A102-weekperiod
ofchemical administrationwasfollowed byan additional
2-week observation period for mice.
Inboth species adequatenumbers ofanimals survived
sufficiently long to be at risk from late-developing
tumors.Compound-relatedmeanbodyweightdepression
was observed in mice, but not in rats. In addition, no
significant accelerated mortality or other signs of tox-
icity were associated with the dietary administration of
1-phenyl-3-methyl-5-pyrazolone to rats; therefore, it is
possible thatthecompoundwas notadministered to rats
at the maximum tolerated concentration.
There were no tumors in either sex ofrats or mice for
which a significant positive association could be estab-
lished between chemical administration and incidence.
Under the conditions of this bioassay, there was no
evidence for the carcinogenicity of1-phenyl-3-methyl-5-
pyrazolone to Fischer 344 rats or B6C3F, mice.
Synonyms: 2,4 - dihydro - 5 - methyl - 2 - phenyl - 3H -
pyrazol-3-one; 3-methyl-1-phenyl-2-pyrazolin-5-one;
phenyl-3-methylpyrazolone; 1-phenyl-3-methyl-5-oxo-2-
pyrazoline; 1-phenyl-5-(3-methylpyrazolone); nor-
phenazone; Developer Z; C.I. Developer 1
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Negative
Male Mice: Negative
Female Mice: Negative
TR-142 Bioassay ofp-Cresidine for
Possible Carcinogenicity (CAS No.
120-71-8)
p-Cresidine,usedintheproductionofvariousazodyes,
was selected for bioassay by the National Cancer
Institute in response to the high incidence of bladder
cancer observed among dye manufacturing industry
workers. Aromatic amines are one class of chemicals
believed to contribute totheincreased cancerriskinthis
industry.
A bioassay ofp-cresidine for possible carcinogenicity
was conductedusingFischer344 rats and B6C3F1 mice.
p-Cresidinewasadministeredinthefeed, ateitheroftwo
concentrations, to groups of 50 male and 50 female
animals ofeach species. Thedietaryconcentrations used
in the chronic bioassay for low and high dose rats were
0.5and1.0percent,respectively. Thetime-weighted aver-
ageconcentrationsfedtolowdosemale,lowdosefemale,
highdosemaleandhighdosefemalemicewere0.22,0.22.
0.46, and 0.44 percent, respectively.
All dosed animals, except for high dose male mice,
were administered p-cresidine in the diet for 104 weeks
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and observed for an additional period of up to 2 weeks.
Allhigh dosemalemicewere deadbythe end ofweek92.
For each species, 50 animals ofeach sex were placed on
test as controls and fed only the basal laboratory diet.
Mortality rates were dose-related for both sexes of
both species. That incidences of certain tumors were
higherinlowdosethaninhighdosegroupswasprobably
due to accelerated mortality in the high dose group.
In dosed rats of both sexes, statistically significant
incidencesofbladdercarcinomas (combinedincidencesof
papillary carcinomas, squamous-cell carcinomas,
transitional-cell papillomas,transitional-cell carcinomas,
and undifferentiated carcinomas) and olfactory neu-
roblastomas were observed. The combined incidence of
neoplastic nodules oftheliver, hepatocelularcarcinomas,
or mixed hepato/cholangio carcinomas was also signifi-
cant in low dose male rats.
In both male and female dosed mice, the incidence of
bladder carcinomas (combined incidence of carcinomas
NOS, squamous-cell carcinomas, and transitional car-
cinomas) was signiflcant. Theincidence ofhepatocellular
carcinomas was also significant in dosed female mice.
Under the conditions ofthis bioassay, p-cresidine was
carcinogenic to Fischer 344 rats, causing increased inci-
dences of carcinomas and of papillomas of the urinary
bladder in both sexes, increased incidences of olfactory
neuroblastomas in both sexes, and of liver tumors in
males. p-Cresidine was also carcinogenic in B6C3F1
mice, causingcarcinomas oftheurinarybladders inboth
sexes and hepatocellular carcinomas in females.
Synonyms: 2-methoxy-5-methylbenzeneamine; 2-meth-
oxy- 5-methylaniline; 5-methyl-o-anisidine; m-amino-
p-cresol methyl ether; MASO; cresidine
Report Date: 1979
Levels ofEvidence ofCarcinogenicity:
Male Rats: Positive
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-143 Bioassay of1,5-
Naphthalenediamine for Possible
Carcinogenicity (CAS No. 2243-62-1)
1,5-Naphthalenediamine, a bicyclic aromatic amine
usedinthedyeindustry,was selectedforbioassaybythe
National Cancer Institute because ofthe high incidence
of bladder cancer reported among dye manufacturing
workers. Aromatic amines are one ofa class ofchemicals
believed to contribute to theincreased cancerriskinthis
industry.
Abioassay of1,5-naphthalenediamine forpossible car-
cinogenicity was conducted using Fischer 344 rats and
B6C3F1 mice. 1,5-Naphthalenediamine was admin-
istered in the feed, at either of two concentrations, to
groups of50 male and 50 female animals ofeach species.
The high and low dietary concentrations utilized in the
chronic bioassay were, respectively, 0.1 and 0.05 percent
for rats and 0.2 and 0.1 percent for mice. The compound
wasadministeredinthedietfor103weeks,followedbyup
to 4 weeks ofobservation. Fifty mice ofeach sex and 25
rats of each sex were placed on test as controls. These
animals were observed for up to 110 weeks.
There were no significant positive associations
between the administered concentrations of 1,5-
naphthalenediamine andmortalityineithersexofrats or
mice. In all groups adequate numbers of animals sur-
vived sufficiently long to be at risk from late-developing
tumors.
Among dosed female rats, a statistically significant
increase in endometrial stromal polyps was observed.
Several ofthese tumors underwent malignant transfor-
mation to endometrial stromal sarcomas. The incidence
offemale rats havingeitheradenoma orcarcinomaofthe
clitoral glandwas statistically significant. No neoplasms
were observed at significantly increased incidences in
dosed male rats. Based onlack ofclinical signs orweight
loss, the male rats may have been able to withstand a
higher dose.
In mice, dose-related increases in thyroid neoplasms
were observed in both sexes. The incidence of thyroid
C-cell carcinomas was significant for high dose female
mice. The combined incidences of papillary adenomas,
follicular-cell adenomas and papillary cystadenomas of
the thyroid were significant for mice ofboth sexes. The
incidence ofhepatocellular carcinomas and the incidence
of alveolar/bronchiolar adenomas were each significant
for dosed female mice.
Under the conditions of this bioassay, 1,5-
naphthalenediamine was carcinogenic in female Fischer
344 rats, causing clitoral and uterine neoplasms. 1,5-
Naphthalenediamine was also carcinogenic for B6C3F1
mice, producing thyroid neoplasms in males and neo-
plasms ofthe thyroid, liver, and lung in females. Insuffi-
cientevidencewasprovidedforthecarcinogenicity ofthe
compound in male Fischer 344 rats.
Synonym: 1,5-diaminonaphthalene
Report Date: 1978
Levels ofEvidence ofCarcinogenicity:
Male Rats: Negative
Female Rats: Positive
Male Mice: Positive
Female Mice: Positive
TR-144 Bioassay of
2-Aminoanthraquinone for Possible
Carcinogenicity (CAS No.117-79-3)
2-Aminoanthraquinone, an intermediate in the syn-
thesis of anthraquinone dyes, was selected for bioassay
by the National Cancer Institute in an attempt to deter-
mine which chemicals may be responsible for the